?

Discussions and Knowledge Gaps

4

Why does beta-adrenergic blockade, which targets the mechanism that causes takotsubo syndrome, fail to improve survival or prevent recurrence?

CONTROVERSY OPEN beta_blockade_mechanism_outcome_gap

Attached to

pathophysiology#Sympathoadrenal activation and catecholamine surge pathophysiology#Beta2-adrenergic receptor switch from Gs to Gi coupling pathophysiology#Coronary microvascular dysfunction

Every element of the accepted mechanism predicts that beta-blockade should work: the trigger is a catecholamine surge, the molecular lesion is a beta2-adrenergic receptor switch, and in animals combined adrenoceptor blockade abolishes the ballooning. Registry data nonetheless show no survival benefit, and a third of patients recur while taking a beta-blocker. Several explanations are live and mutually compatible. Alpha-adrenergic receptors dominate the coronary microcirculation and are untouched by beta-blockade, which would matter if the microvascular arm carries more causal weight than assumed. The animal evidence required combined alpha and beta blockade, not beta alone, so the preclinical result may never have supported beta-monotherapy. Blockade started after presentation cannot prevent a surge that has already happened, so an acute-phase trial may be testing the wrong window. And if the receptor switch is partly cardioprotective rather than purely injurious, blocking it could offset its own benefit. Distinguishing these matters because they imply different drugs and different timing.

Proposed experiments

Randomised trial of combined alpha- and beta-adrenoceptor blockade versus beta-blockade alone for recurrence prevention

exp_tts_combined_alpha_beta_blockade_trial

Randomise takotsubo survivors at hospital discharge to a combined alpha- and beta-blocking agent, a selective beta-blocker, or renin-angiotensin blockade alone, and follow recurrence, major adverse cardiovascular events, and global longitudinal strain for three years.

Decision criterion

A reduction in recurrence with combined blockade but not with beta-blockade alone would support the alpha-receptor and microvascular explanation and would reconcile the animal and clinical evidence; equivalence across all three arms would argue that adrenergic blockade after the index event is simply too late.

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"In contrast, there was no evidence of any survival benefit for the use of beta-blockers.2 Moreover, one-third of patients experienced a TTS recurrence during beta-blockade2 suggesting that other receptors such as alpha-receptors, that are more prevalent in the coronary microcirculation, might be..."

States both the negative outcome and the consensus document's own proposed explanation for it.

Is the limbic and autonomic network hypoconnectivity seen in takotsubo patients a pre-existing vulnerability that permits the syndrome, or a consequence of having had it?

KNOWLEDGE GAP OPEN brain_heart_axis_causal_direction

Attached to

pathophysiology#Central limbic and autonomic network hypoconnectivity

The imaging is unambiguous that connectivity in sympathetic- and parasympathetic-associated subnetworks is reduced, involving exactly the regions that generate autonomic outflow. The direction of causation is not established, because every published cohort was scanned after the cardiac event. The distinction is not academic: a pre-existing central lesion would make takotsubo a disorder of autonomic regulation that happens to present cardiologically, would explain why some patients recur and others never do, and would make central rather than cardiac intervention the rational target. A reactive change would instead make the brain findings a marker of illness severity.

Proposed experiments

Prospective neuroimaging in a population at elevated takotsubo risk

exp_tts_prospective_neuroimaging_cohort

Acquire resting-state functional magnetic resonance imaging in a large cohort scanned for unrelated indications or as part of a population imaging study, then ascertain incident takotsubo syndrome over subsequent years and compare baseline limbic and autonomic connectivity in those who develop the syndrome against matched controls who do not.

Decision criterion

Reduced baseline connectivity preceding the event would establish it as a predisposing lesion; connectivity indistinguishable from controls before the event, with the abnormality appearing only afterwards, would establish it as reactive.

Show evidence (1 reference)

PMID:30831580 SUPPORT Human Clinical

"We found parasympathetic- and sympathetic-associated subnetworks both showing reduced resting state functional connectivity in TTS patients compared with controls."

The observation whose temporal direction is the open question; the study design is cross-sectional and post-event.

Do rodent immobilisation and catecholamine-infusion models reproduce the biology responsible for the overwhelming postmenopausal female predominance of takotsubo syndrome in humans?

HUMAN MODEL MISMATCH OPEN animal_models_and_the_sex_bias

Attached to

pathophysiology#Beta2-adrenergic receptor switch from Gs to Gi coupling pathophysiology#Central limbic and autonomic network hypoconnectivity

The animal models are genuinely strong on the core mechanism: immobilisation stress and epinephrine boluses reproduce the ST changes, the apical ballooning, and the reversibility, and pharmacologic blockade abolishes them. What they reproduce far less well is the single most striking epidemiologic fact about the human syndrome, that roughly nine in ten patients are postmenopausal women. Rat work shows that raising serum estrogen partially attenuates the cardiac changes, which is a real signal in the right direction but a much weaker effect than a nine-to-one sex ratio implies, and the models do not address the human limbic and insular findings at all. Two readings follow. Either the sex bias arises from a mechanism the models do not capture, in which case negative model results for hormone-directed interventions are uninformative about patients; or estrogen modulation of beta-adrenergic coupling is the right mechanism and the models simply underpower it. This matters directly for whether hormone-related susceptibility is worth pursuing therapeutically.

Proposed experiments

Aged ovariectomised rodent model with graded estrogen replacement

exp_tts_ovariectomised_aged_model

Compare takotsubo induction rate and severity across intact young, intact aged, ovariectomised aged, and ovariectomised aged animals receiving graded estrogen replacement, using a standardised epinephrine bolus, with beta2-adrenergic receptor density and Gs-to-Gi coupling measured in apical and basal cardiomyocytes from each group.

Decision criterion

A susceptibility gradient tracking estrogen exposure, with a matching shift in apical beta2-adrenergic receptor coupling, would establish the hormonal mechanism as sufficient to explain the human sex bias; a comparable induction rate across hormone states would show the models lack the relevant biology and would redirect attention to the central autonomic arm.

Show evidence (2 references)

PMID:15240400 SUPPORT Model Organism

"An increase of serum estrogen partially attenuated these cardiac changes."

The estrogen signal in the rat model is real but explicitly partial, which is the mismatch against a nine-to-one human sex ratio.

PMID:26332547 SUPPORT Human Clinical

"Of 1750 patients with takotsubo cardiomyopathy, 89.8% were women (mean age, 66.8 years)."

The human sex and age distribution that the models are being asked to reproduce.

Is there a genuine heritable component to takotsubo susceptibility, and if so why has no locus replicated despite two decades of candidate-gene work?

KNOWLEDGE GAP OPEN polygenic_susceptibility_absent_locus

Attached to

pathophysiology#Beta2-adrenergic receptor switch from Gs to Gi coupling

Familial clustering has been reported repeatedly, and the adrenergic pathway supplies unusually well-motivated candidate genes, ADRB2 above all, since it encodes the receptor through which the leading mechanism operates. Yet no variant has been conclusively associated, and the field has moved to a polygenic and gene-environment framing largely by elimination. Three explanations remain open. The effect may be genuinely polygenic with per-variant effects far below what candidate-gene sample sizes can detect. The heritable component may not be cardiac at all but reside in central stress-response and autonomic regulation, in which case adrenergic candidate genes were the wrong place to look. Or the familial reports may reflect shared environment and ascertainment rather than genetics. Resolving this determines whether a susceptibility panel is a realistic goal or a category error.

Proposed experiments

Adequately powered multinational genome-wide association study of takotsubo syndrome

exp_tts_gwas_consortium

Pool takotsubo cases across the international registries with matched controls to reach a sample size capable of detecting common variants of modest effect, test for enrichment in adrenergic, stress-response, and neuropsychiatric pathways, and evaluate whether a polygenic score derived in one cohort predicts case status in an independent one.

Decision criterion

Replicated genome-wide significant loci, or a polygenic score that transfers between cohorts, would establish a heritable component and localise it; a well-powered null would make a shared-environment explanation the leading account of familial clustering.

Show evidence (1 reference)

PMID:40723798 SUPPORT Human Clinical

"Despite a large number of investigations, no definitive genetic markers associated with TS risk have been conclusively identified. The lack of a clear Mendelian inheritance pattern suggests a multifactorial etiology and pathogenesis, likely involving complex gene-environment interactions and a..."

States the negative result and the polygenic reframing that the proposed study would test directly.

⚙

Pathophysiology

13

Acute emotional or physical stressor

The initiating event is an acute stressor: bereavement, fear, anger, or interpersonal conflict on the emotional side; surgery, sepsis, respiratory failure, seizure, intracranial haemorrhage, or trauma on the physical side. Contemporary registry data overturned the original "broken heart" framing by showing that physical triggers are at least as common as emotional ones, and that patients with physical or neurologic triggers do worse. A minority of cases have no identifiable trigger at all, which is itself an argument against a purely reactive model.

Downstream

Sympathoadrenal activation and catecholamine surge The stressor activates the sympathetic nervous system and adrenal medulla, releasing catecholamines into the circulation and from cardiac sympathetic nerve terminals.

Show evidence (2 references)

PMID:26332547 SUPPORT Human Clinical

"Emotional triggers were not as common as physical triggers"

International Takotsubo Registry finding in 1750 patients that reversed the prior assumption that emotional stress dominates.

PMID:15703419 SUPPORT Human Clinical

"We evaluated 19 patients who presented with left ventricular dysfunction after sudden emotional stress."

The defining case series, in which the emotional stressor is the enrolment criterion.

Sympathoadrenal activation and catecholamine surge

Plasma epinephrine, norepinephrine, and dopamine rise steeply, to levels several-fold above those measured in patients with severe myocardial infarction and pulmonary oedema. The comparison matters: it is not simply that catecholamines are elevated in a sick patient, but that they are elevated far beyond what comparable haemodynamic stress produces. Endogenous catecholamine excess from pheochromocytoma, and iatrogenic epinephrine administration, reproduce the syndrome, which is the strongest available argument that the surge is causal rather than reactive.

Adrenal medullary chromaffin cell CL:0000166

cellular response to catecholamine stimulus GO:0071870 ↑ INCREASED

Downstream

Beta2-adrenergic receptor switch from Gs to Gi coupling Supraphysiologic epinephrine concentrations drive the beta2-adrenergic receptor into inhibitory G-protein coupling.

Cardiomyocyte calcium overload and oxidative stress Sustained adrenergic overstimulation of cardiomyocytes drives intracellular calcium loading and reactive oxygen species generation.

Coronary microvascular dysfunction Catecholamine excess constricts and impairs the coronary microcirculation.

Show evidence (1 reference)

PMID:15703419 SUPPORT Human Clinical

"Plasma catecholamine levels at presentation were markedly higher among patients with stress-induced cardiomyopathy than among those with Killip class III myocardial infarction"

The comparison that makes the surge specific to the syndrome rather than to critical illness generally.

Beta2-adrenergic receptor switch from Gs to Gi coupling

The leading molecular explanation for why the apex fails while the base becomes hypercontractile. At physiologic epinephrine levels the beta2-adrenergic receptor couples to stimulatory Gs and is inotropic. At the supraphysiologic levels reached in a catecholamine surge the receptor switches to inhibitory Gi, converting the same ligand into a negative inotropic and cardioprotective signal. Because beta2-receptor density and responsiveness are highest in apical cardiomyocytes, the switch is expressed as regional apical cardiodepression. Blocking Gi with pertussis toxin abolishes the apical depression, which is the causal test.

Apical cardiomyocyte CL:0000746

adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway GO:0007193 ↑ INCREASED

beta2-adrenergic receptor activity GO:0004941 ⇑ GAIN OF FUNCTION

Left ventricle UBERON:0002084

Downstream

Reversible regional wall motion abnormality Negative inotropy confined to the beta2-receptor-rich apex produces apical akinesis with preserved or exaggerated basal contraction.

Show evidence (2 references)

PMID:22732314 SUPPORT Model Organism

"The effect is prevented via G(i) inactivation by pertussis toxin pretreatment."

The interventional test, in which removing Gi signalling removes the apical depression, establishing the switch as causal rather than correlated.

PMID:22732314 SUPPORT In Vitro

"In vitro studies demonstrated high-dose epinephrine can induce direct cardiomyocyte cardiodepression and cardioprotection in a β(2)AR-Gi-dependent manner."

Shows the switch operates at the level of the isolated cardiomyocyte, independent of vascular or neural intermediaries.

Cardiomyocyte calcium overload and oxidative stress

Beta-adrenergic overstimulation loads the cardiomyocyte with calcium, generates reactive oxygen species, and impairs mitochondrial energetics. This is the classical catecholamine cardiotoxicity mechanism, shared with pheochromocytoma crisis and subarachnoid haemorrhage, and it is what produces the histologic lesion below. It is a parallel arm to the receptor switch rather than a consequence of it: the switch explains the regional distribution, this explains the tissue injury.

Cardiomyocyte CL:0000746

intracellular calcium ion homeostasis GO:0006874 ⚠ ABNORMAL response to oxidative stress GO:0006979 ↑ INCREASED

Downstream

Contraction band necrosis and focal myocytolysis Calcium overload drives hypercontraction of sarcomeres, producing the contraction band lesion.

Show evidence (1 reference)

PMID:35344411 SUPPORT Human Clinical

"Catecholamine-induced myocardial injury is the most established and well-known theory, but this does not explain all the clinical features and presentations of the condition, and numerous other pathways and abnormalities are emerging."

States catecholamine cardiotoxicity as the best-established mechanism while explicitly flagging it as incomplete, which is why this node sits parallel to the others rather than upstream of them.

Contraction band necrosis and focal myocytolysis

The histologic signature, seen on endomyocardial biopsy: hypercontracted sarcomeres with dense eosinophilic transverse bands, focal myocyte dropout, and a mononuclear rather than neutrophilic infiltrate. It is qualitatively different from the coagulative necrosis of infarction, and it is reversible, which is the tissue-level reason the ventricle recovers. The same lesion appears in pheochromocytoma and in neurogenic stunned myocardium, tying the three catecholamine-excess states together.

Left ventricular myocardium UBERON:0006566

Downstream

Myocardial macrophage inflammatory infiltrate Injured and dying myocytes recruit macrophages into the myocardium.

Show evidence (1 reference)

PMID:15703419 SUPPORT Human Clinical

"Endomyocardial biopsy showed mononuclear infiltrates and contraction-band necrosis."

Direct human histology from the defining case series.

Coronary microvascular dysfunction

Coronary flow reserve is impaired and microcirculatory resistance is elevated in the acute phase despite angiographically unobstructed epicardial arteries. Whether this is a primary driver of the stunning or a consequence of the same catecholamine surge acting on the microvasculature is unresolved, and the alpha-adrenergic receptors that dominate the coronary microcirculation are one proposed reason beta-blockade alone fails to prevent recurrence.

Cardiac endothelial cell CL:0010008

Downstream

Reversible regional wall motion abnormality Regional hypoperfusion from microvascular constriction contributes to the regional contractile failure, additively with the receptor switch.

Chest pain Microvascular ischaemia, alongside the acute regional contractile failure it contributes to, is the proposed substrate for anginal chest pain in a patient with unobstructed epicardial arteries.

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"suggesting that other receptors such as alpha-receptors, that are more prevalent in the coronary microcirculation, might be involved"

The consensus statement's own inference from beta-blocker failure, pointing at alpha-adrenergic control of the coronary microcirculation; PARTIAL because it is an inference offered as hypothesis.

Myocardial macrophage inflammatory infiltrate

Iron-oxide-enhanced cardiac magnetic resonance shows macrophage accumulation in both ballooning and non-ballooning left ventricular segments, accompanied by a shift in circulating monocyte subsets and raised interleukin-6 and CXCL1. Two findings make this more than an epiphenomenon of injury. First, the infiltrate is present in segments that are contracting normally, so it is not simply a reaction to regional akinesis. Second, the systemic inflammatory changes persist for months after the myocardial signal has resolved, which is the best current mechanistic candidate for the persistent subclinical dysfunction seen in survivors.

Cardiac macrophage CL:0000235 Classical monocyte CL:0000576

inflammatory response GO:0006954 ↑ INCREASED

Downstream

Persistent subclinical myocardial dysfunction A low-grade chronic inflammatory state outlasting the acute event is the proposed substrate for continuing symptoms after ejection fraction recovers.

Show evidence (2 references)

PMID:30586731 SUPPORT Human Clinical

"patients with takotsubo cardiomyopathy had greater USPIO enhancement (expressed as the difference between pre-USPIO and post-USPIO T2*) in both ballooning"

Shows the macrophage signal is present in ballooning segments; the same sentence continues to report it in non-ballooning segments too.

PMID:30586731 SUPPORT Human Clinical

"Serum interleukin-6 (23.1±4.5 pg/mL versus 6.5±5.8 pg/mL; P<0.001) and chemokine (C-X-C motif) ligand 1 (1903±168 pg/mL versus 1272±177 pg/mL; P=0.01) concentrations and classic CD14++CD16- monocytes (90±0.5% versus 87±0.9%; P=0.01) were also increased"

Quantifies the systemic inflammatory arm against matched controls.

Central limbic and autonomic network hypoconnectivity

Resting-state functional magnetic resonance imaging in takotsubo survivors shows reduced connectivity in both sympathetic- and parasympathetic-associated subnetworks, involving amygdala, hippocampus, insula, and cingulate cortex. The direction of causation is the open question and is curated as such: these are the regions that generate and regulate the autonomic outflow, so reduced integration is a plausible predisposing lesion, but the imaging is done after the cardiac event, so it is equally compatible with the event having altered the brain.

Downstream

Sympathoadrenal activation and catecholamine surge Impaired central autonomic integration is proposed to permit an unrestrained sympathetic discharge in response to a stressor.

Show evidence (2 references)

PMID:30831580 SUPPORT Human Clinical

"We found parasympathetic- and sympathetic-associated subnetworks both showing reduced resting state functional connectivity in TTS patients compared with controls."

The primary finding, in 15 takotsubo patients against 39 healthy controls.

PMID:30831580 SUPPORT Human Clinical

"Important brain regions constituting parasympathetic- and sympathetic-associated subnetworks included the amygdala, hippocampus, and insula as well as cingulate, parietal, temporal, and cerebellar regions."

Localises the abnormality to the limbic-autonomic regions that generate sympathetic outflow.

Reversible regional wall motion abnormality

The defining lesion: a circumferential regional wall-motion abnormality that extends beyond the territory of any single epicardial coronary artery. The apical-ballooning variant, with akinetic apex and hypercontractile base, is the commonest, but mid-ventricular, basal ("reverse"), and focal variants exist and a patient who recurs often does so in a different pattern. The circumferential distribution is what makes the diagnosis at ventriculography, because no coronary occlusion produces it.

Left ventricle UBERON:0002084

Downstream

Acute left ventricular systolic dysfunction Loss of contraction over a large contiguous territory drops global ejection fraction.

Dynamic left ventricular outflow tract obstruction Basal hypercontractility with an akinetic apex accelerates flow through a narrowed outflow tract and draws the mitral leaflet forward.

Left ventricular mural thrombus Blood stagnating in the akinetic apical cavity forms thrombus.

Show evidence (1 reference)

PMID:33602474 SUPPORT Human Clinical

"a typical pattern of circumferential left ventricular wall motion abnormalities that usually involve the apical and midventricular myocardium"

Defines the circumferential, apical-predominant distribution that separates the lesion from infarction.

Acute left ventricular systolic dysfunction

Ejection fraction at presentation is severely reduced, typically well below that of matched acute coronary syndrome patients, and drives the clinical syndrome of acute heart failure, pulmonary oedema, and in a minority cardiogenic shock. Recovery is the rule and is fast, usually complete within two to four weeks.

Downstream

Persistent subclinical myocardial dysfunction Recovery of ejection fraction is not recovery of myocardial function; strain and energetic abnormalities outlast it.

Pulmonary edema The abrupt fall in systolic function raises left atrial and pulmonary venous pressure, producing acute pulmonary congestion.

Congestive heart failure Acute systolic impairment over a large contiguous myocardial territory produces the clinical syndrome of acute heart failure, the commonest in-hospital complication.

Atrial fibrillation Elevated filling pressures and atrial stretch from the acute fall in systolic function precipitate the commonest arrhythmic complication.

Show evidence (2 references)

PMID:26332547 SUPPORT Human Clinical

"the mean left ventricular ejection fraction was markedly lower (40.7±11.2% vs. 51.5±12.3%)"

Registry comparison against age- and sex-matched acute coronary syndrome patients, showing the systolic impairment is more severe than in the condition it mimics.

PMID:15703419 SUPPORT Human Clinical

"rapidly resolved in all patients"

Establishes reversibility as the defining course.

Dynamic left ventricular outflow tract obstruction

Present in roughly one in five patients and the single most important reason takotsubo is not managed like other acute heart failure. The obstruction is dynamic and preload-dependent, so inotropes and nitrates worsen it, and it is the mechanism by which standard heart-failure reflexes make a shocked takotsubo patient worse rather than better. It must be looked for before catecholamines are given, not after.

Downstream

Cardiogenic shock Obstruction to ejection compounds the systolic failure and precipitates shock.

Show evidence (2 references)

PMID:32473281 SUPPORT Human Clinical

"Cardiogenic shock occurs in 10%-15% of patients with Takotsubo syndrome (TS)."

Independent estimate of shock incidence, higher than the national inpatient figure elsewhere in this entry, and worth recording as a range rather than a single number.

PMID:29850820 SUPPORT Human Clinical

"the administration of nitroglycerin in the presence of LVOTO has been found to worsen the pressure gradient and therefore should be avoided in this scenario"

Documents the therapeutic trap that makes recognising the obstruction consequential.

Left ventricular mural thrombus

Thrombus forms in the akinetic apex during the acute phase and is the principal cardioembolic source in a syndrome that is otherwise not thrombotic. Because the akinesis is temporary, so is the indication for anticoagulation, which is an unusual situation and a recognised source of both under- and over-treatment.

Left ventricle UBERON:0002084

Downstream

Stroke Apical thrombus embolises to the cerebral circulation.

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"as well as thrombus formation within a dysfunctional LV apex"

Documents thrombus forming specifically within the dysfunctional apex, which ties the thrombus to the regional akinesis rather than to a general prothrombotic state.

Persistent subclinical myocardial dysfunction

The finding that most changed how the syndrome is regarded. Global longitudinal strain and cardiac energetic reserve remain abnormal after ejection fraction has normalised, survivors continue to report fatigue, dyspnoea, and exercise intolerance, and long-term major adverse cardiovascular event rates approach those after acute coronary syndrome. Takotsubo is therefore better described as an acute event on a background of enduring vulnerability than as a self-limited illness, which is also consistent with the four to ten percent recurrence rate.

Downstream

Anxiety Ongoing subclinical cardiac limitation and enduring vulnerability are proposed to sustain psychological distress that commonly follows the acute event, alongside the pre-existing anxiety burden that predisposes to it in the first place; the direction between cardiac and psychiatric disease here is genuinely bidirectional.

Show evidence (1 reference)

PMID:35344411 SUPPORT Human Clinical

"Moreover, these patients have a substantial burden of morbidity and mortality, as well, with high rates of subsequent major adverse cardiovascular events that approach those of patients with acute coronary syndrome."

Quantifies the long-term consequence that contradicts the historical benign framing.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

19

Cardiovascular 7

T-wave inversion VERY_FREQUENT HP:0010872

Temporal: SUBACUTE

Show evidence (1 reference)

PMID:15703419 SUPPORT Human Clinical

"Diffuse T-wave inversion and a prolonged QT interval occurred in most patients."

Documents both the finding and its frequency in the defining series.

Prolonged QT interval VERY_FREQUENT HP:0001657

Temporal: ACUTE

Sequelae: Torsade de pointes

Show evidence (1 reference)

PMID:15703419 SUPPORT Human Clinical

"Diffuse T-wave inversion and a prolonged QT interval occurred in most patients."

Supports both the association and the "most patients" frequency band.

Reduced left ventricular ejection fraction VERY_FREQUENT HP:0012664

Temporal: TRANSIENT

Show evidence (1 reference)

PMID:26332547 SUPPORT Human Clinical

"the mean left ventricular ejection fraction was markedly lower (40.7±11.2% vs. 51.5±12.3%)"

Registry mean ejection fraction against matched acute coronary syndrome controls.

Congestive heart failure FREQUENT HP:0001635

Temporal: ACUTE

Show evidence (1 reference)

PMID:40365782 SUPPORT Human Clinical

"congestive heart failure in 35.9%"

Frequency from 199 890 admissions in the Nationwide Inpatient Sample, supporting the FREQUENT band.

Atrial fibrillation FREQUENT HP:0005110

Temporal: ACUTE

Show evidence (1 reference)

PMID:40365782 SUPPORT Human Clinical

"Cardiogenic shock occurred in 6.6%, atrial fibrillation in 20.7%, cardiac arrest in 3.4%, congestive heart failure in 35.9%, and stroke in 5.3%."

Frequency from the national inpatient cohort, supporting the FREQUENT band.

Cardiac arrest OCCASIONAL HP:0001695

Temporal: ACUTE

Show evidence (1 reference)

PMID:40365782 SUPPORT Human Clinical

"Cardiogenic shock occurred in 6.6%, atrial fibrillation in 20.7%, cardiac arrest in 3.4%, congestive heart failure in 35.9%, and stroke in 5.3%."

Frequency from the national inpatient cohort.

Stroke OCCASIONAL HP:0001297

Temporal: ACUTE

Show evidence (1 reference)

PMID:40365782 SUPPORT Human Clinical

"Cardiogenic shock occurred in 6.6%, atrial fibrillation in 20.7%, cardiac arrest in 3.4%, congestive heart failure in 35.9%, and stroke in 5.3%."

Frequency from the national inpatient cohort.

Metabolism 1

Pulmonary edema HP:0100598

Temporal: ACUTE

Sequelae: Dyspnea

Show evidence (1 reference)

PMID:15703419 SUPPORT Human Clinical

"Clinical presentations included chest pain, pulmonary edema, and cardiogenic shock."

Documents pulmonary oedema as a presenting manifestation.

Nervous System 1

Anxiety HP:0000739

Temporal: CHRONIC

Show evidence (1 reference)

PMID:26332547 SUPPORT Human Clinical

"rates of neurologic or psychiatric disorders were higher (55.8% vs. 25.7%)"

Quantifies the excess psychiatric and neurologic burden relative to matched acute coronary syndrome patients.

Respiratory 1

Dyspnea FREQUENT HP:0002094

Temporal: ACUTE

Show evidence (1 reference)

PMID:33602474 SUPPORT Human Clinical

"TTS is now routinely diagnosed in patients who present with acute chest pain, electrocardiographic changes, troponin elevation, unobstructed coronary arteries"

Establishes the acute cardiorespiratory presentation; PARTIAL because dyspnoea is not itemised separately in the abstract.

Constitutional 1

Chest pain VERY_FREQUENT HP:0100749

Temporal: ACUTE

Show evidence (1 reference)

PMID:15703419 SUPPORT Human Clinical

"Clinical presentations included chest pain, pulmonary edema, and cardiogenic shock."

Lists chest pain first among presenting features in the defining series.

Other 8

ST segment elevation FREQUENT HP:0012251

Temporal: ACUTE

Show evidence (2 references)

PMID:29850820 SUPPORT Human Clinical

"In the InterTAK Registry, ST-segment elevation was present in 44%, ST-segment depression in 8%, T-wave inversion in 41%, and left bundle branch block in 5%."

Registry frequency supporting the FREQUENT band, and the reason this is not VERY_FREQUENT. ST elevation is present in fewer than half of patients, so an ECG without it does not argue against the diagnosis.

PMID:15240400 SUPPORT Model Organism

"which is characterized by an elevation of the ST segment in the electrocardiogram (ECG) and left ventricular apical ballooning in the left ventriculogram (LVG)"

Secondary support only. The publication reports a rat immobilisation-stress model, so it is tagged MODEL_ORGANISM; the quoted line is its introductory description of the human syndrome, which is why it is PARTIAL rather than primary evidence for a human phenotype.

Torsade de pointes OCCASIONAL HP:0001664

Temporal: ACUTE

Sequelae: Cardiac arrest

Show evidence (2 references)

PMID:29850820 SUPPORT Human Clinical

"Life-threatening ventricular arrhythmias, such as torsades de pointes, VT, or VF occur in 3.0–8.6% and are a frequent cause of death."

Gives the rate supporting the OCCASIONAL band, and states that these arrhythmias are a frequent cause of death, which is why QT management matters so much here.

PMID:29850820 SUPPORT Human Clinical

"due to the potential risk of pause-dependent torsades de pointes, beta-blockers should be used cautiously, especially in patients with bradycardia and QTc >500 ms"

Names the arrhythmia and the electrophysiologic context in which it occurs.

Regional left ventricular wall motion abnormality OBLIGATE HP:0012667

Temporal: TRANSIENT

Show evidence (1 reference)

PMID:33602474 SUPPORT Human Clinical

"a typical pattern of circumferential left ventricular wall motion abnormalities that usually involve the apical and midventricular myocardium"

Describes the obligate imaging finding and its distribution.

Cardiogenic shock OCCASIONAL HP:0030149

Temporal: ACUTE

Sequelae: Cardiac arrest

Show evidence (1 reference)

PMID:40365782 SUPPORT Human Clinical

"Cardiogenic shock occurred in 6.6%"

Frequency from the national inpatient cohort, supporting the OCCASIONAL band.

Left ventricular outflow tract obstruction FREQUENT HP:0032092

Temporal: TRANSIENT

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"the presence of LVOTO, which occurs in about 20% of cases"

Consensus-stated frequency supporting the FREQUENT band.

Left ventricular thrombus HP:0040412

Temporal: TRANSIENT

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"Severe LV dysfunction with extended apical ballooning entails the risk of an LV thrombus and subsequent systemic embolism."

Ties the thrombus explicitly to extended apical ballooning and states the embolic consequence.

Elevated cardiac troponin VERY_FREQUENT Increased circulating troponin I concentration HP:0410173

Temporal: ACUTE

Show evidence (1 reference)

PMID:15703419 SUPPORT Human Clinical

"Seventeen patients had mildly elevated serum troponin I levels"

Documents both the elevation and its modest magnitude in 17 of 19 patients.

Elevated brain natriuretic peptide VERY_FREQUENT Increased circulating brain natriuretic peptide concentration HP:0033534

Temporal: ACUTE

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"Takotsubo syndrome is frequently associated with a substantial increase in the plasma levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) reaching its peak approximately 24–48 h after symptom onset"

States both the elevation and that it is a frequent feature, which is what the VERY_FREQUENT band rests on, and dates the peak to 24 to 48 hours.

🧬

Genetic Associations

3

ADRB1

Gene: ADRB1 hgnc:285 relationship_type: UNKNOWN variant_origin: GERMLINE

ADRB2

Gene: ADRB2 hgnc:286 relationship_type: UNKNOWN variant_origin: GERMLINE

GRK5

Gene: GRK5 hgnc:4544 relationship_type: UNKNOWN variant_origin: GERMLINE

💊

Medical Actions

8

Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy

Action: Pharmacotherapy NCIT:C15986

Agent: ACE inhibitor NCIT:C247

Platform: Small molecule

The only pharmacologic class with registry evidence of a survival signal in this syndrome, and the one associated with lower recurrence. The evidence is observational and propensity-matched rather than randomised, so it supports a preference rather than a proven benefit, but the asymmetry against beta-blockade in the same dataset is the reason these agents are usually the first long-term choice.

Mechanism Target:

MODULATES Acute left ventricular systolic dysfunction — Afterload reduction and neurohormonal blockade support recovery of left ventricular function and are associated with improved survival.

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"The use of ACEi or ARB was associated with improved survival at 1-year follow-up even after propensity matching."

The strongest available treatment-outcome association in the syndrome, reported by the consensus document from registry data.

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"Beta-blocker therapy after hospital discharge does not appear to prevent recurrence,2,144 whereas ACEi or ARB are associated with a lower prevalence of recurrence."

Directly contrasts the two long-term options on recurrence, which is the basis for preferring renin-angiotensin blockade.

Beta-adrenergic blockade

Action: Pharmacotherapy NCIT:C15986

Agent: beta-adrenergic antagonist NCIT:C29576

Platform: Small molecule

Mechanistically the most attractive drug in the syndrome and the one that has repeatedly failed to show benefit. Blocking the receptor through which the catecholamine surge acts ought to work, and in animal models combined alpha- and beta-blockade does attenuate the ballooning. In patients, registry data show no survival benefit and no reduction in recurrence, and acute use is constrained by bradycardia, hypotension, low ejection fraction, and the torsade risk of a prolonged QT. Beta-blockade does have a specific acute role in relieving dynamic outflow obstruction. The gap between the mechanism and the outcome is curated as an open controversy.

Mechanism Target:

INHIBITS Dynamic left ventricular outflow tract obstruction — Slowing and reducing basal hypercontractility widens the outflow tract and lowers the gradient.

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"beta-blockers may improve LVOTO, but are contraindicated in acute and severe heart failure with low LVEF, hypotension, and in those with bradycardia"

States both the specific indication and the constraints that limit it.

INHIBITS Sympathoadrenal activation and catecholamine surge — Receptor-level blockade of the catecholamine signal, the mechanistic rationale that clinical outcome data have not borne out.

Show evidence (1 reference)

PMID:15240400 SUPPORT Model Organism

"Immobilization stress (IMO) of rats can reproduce these ECG and LVG changes, both of which are normalized by combined blockade of alpha- and beta-adrenoceptors."

The animal evidence that adrenoceptor blockade prevents the syndrome, which is the rationale; note it required combined alpha and beta blockade, not beta alone.

Show evidence (1 reference)

PMID:29850820 REFUTE Human Clinical

"In contrast, there was no evidence of any survival benefit for the use of beta-blockers.2 Moreover, one-third of patients experienced a TTS recurrence during beta-blockade2"

Refutes the survival and recurrence-prevention rationale for beta-blockade despite its mechanistic appeal.

Anticoagulation for left ventricular thrombus

Action: Pharmacotherapy NCIT:C15986

Agent: anticoagulant NCIT:C263

Platform: Small molecule

Indicated for demonstrated apical thrombus, and considered for extensive apical akinesis with severely depressed function. The unusual feature is that the indication is self-limiting: as the apex recovers, the substrate disappears, so this is one of the few settings in which anticoagulation is started with a planned stop date.

Mechanism Target:

INHIBITS Left ventricular mural thrombus — Anticoagulation prevents propagation and embolisation of apical thrombus while the akinetic segment recovers.

Show evidence (1 reference)

PMID:40365782 SUPPORT Human Clinical

"Cardiogenic shock occurred in 6.6%, atrial fibrillation in 20.7%, cardiac arrest in 3.4%, congestive heart failure in 35.9%, and stroke in 5.3%."

Quantifies the embolic burden that anticoagulation targets; PARTIAL because the cohort study reports the complication rate and not the effect of anticoagulation on it.

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"Although evidence is lacking, anticoagulation with intravenous/subcutaneous heparin would appear to be appropriate in such patients and post-discharge oral anticoagulation or antiplatelet therapy may be considered on an individual, per-patient basis."

The consensus recommendation, stated with its own caveat that the evidence base for it is lacking, which is why this treatment is curated as rationally targeted rather than trial-proven.

Diuretic therapy for pulmonary congestion

Action: Pharmacotherapy NCIT:C15986

Platform: Small molecule

Standard management of the acute pulmonary oedema. Nitrates, which would otherwise be a natural companion, must be withheld if there is outflow tract obstruction, because reducing preload worsens the gradient.

Mechanism Target:

MODULATES Acute left ventricular systolic dysfunction — Decongestion relieves the pulmonary oedema produced by the acute fall in systolic function.

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"Diuretics are indicated in patients with pulmonary oedema."

The consensus indication.

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"nitroglycerin is useful to reduce LV and RV filling pressures and afterload in the case of acute heart failure; however, the administration of nitroglycerin in the presence of LVOTO has been found to worsen the pressure gradient"

Documents the conditional nature of vasodilator use alongside diuresis in this syndrome.

Mechanical circulatory support for refractory shock

Action: percutaneous ventricular assist device placement Ontology label: Percutaneous Ventricular Assist Device Placement NCIT:C172592

Platform: Device

For shock that does not respond, or that cannot be treated with inotropes because of outflow obstruction, temporary mechanical support bridges the patient through the days to weeks until the myocardium recovers. Device choice is dictated by the same physiology: a device that unloads the left ventricle is preferable, whereas veno-arterial extracorporeal support without unloading raises afterload and can worsen an outflow gradient.

Mechanism Target:

BYPASSES Cardiogenic shock — Temporary circulatory support maintains systemic perfusion until spontaneous recovery of ventricular function, which in this syndrome takes days rather than months.

Show evidence (2 references)

PMID:32473281 SUPPORT Human Clinical

"Temporary mechanical circulatory support (MCS) appears attractive as bridge-to-recovery, but prospective studies are lacking."

States the bridge-to-recovery rationale that this edge represents, together with the absence of prospective evidence for it.

PMID:32473281 SUPPORT Human Clinical

"Median time on MCS was 3 (IQR: 2-7) days, with an overall survival of 94.6%."

Quantifies both the short bridging interval the reversible physiology allows and the survival in supported patients, which is the outcome the bypass edge claims.

Show evidence (4 references)

PMID:32473281 SUPPORT Human Clinical

"The overall number of publications on MCS for TS increased over time, as did those using veno-arterial extracorporeal membrane oxygenation (V-A ECMO) and Impella, while those using intra-aortic balloon pump declined."

Documents the shift in device selection toward ventricular unloading and away from the intra-aortic balloon pump, which is the device-choice claim in this treatment's description.

PMID:32473281 SUPPORT Human Clinical

"Currently available clinical data support this approach. Prospective studies are needed to evaluate safety and efficacy of different devices as well as timing of MCS in this special patient population."

The authors' own verdict, supportive but explicitly not prospective; PARTIAL because 93 pooled individual cases with no comparator cannot establish efficacy.

PMID:32473281 SUPPORT Human Clinical

"For several reasons catecholamines, and especially inotropes, should be avoided in TS."

States the reason mechanical rather than pharmacologic support is reached for in this syndrome, from a source about mechanical support rather than about drugs.

+ 1 more reference

Avoidance of catecholamine inotropes

Action: supportive care Ontology label: Supportive Care NCIT:C15747

Platform: Other

A treatment defined by what is withheld. Giving catecholamines to a patient whose disease is caused by a catecholamine surge is mechanistically perverse, and in those with outflow obstruction it is haemodynamically harmful as well. Reported mortality among patients treated with catecholamines is high, though confounded by their being the sickest. Recognising this is arguably the single highest-yield management decision in the syndrome.

Mechanism Target:

INHIBITS Sympathoadrenal activation and catecholamine surge — Withholding exogenous catecholamines avoids compounding the causal exposure.

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"In TTS patients treated with catecholamine drugs a 20% mortality has been reported81"

The outcome signal underlying the avoidance recommendation, reported with its own caveat about selection bias.

Show evidence (1 reference)

PMID:22732314 SUPPORT Model Organism

"It is precipitated by extreme stress and can be triggered by intravenous catecholamine administration, particularly epinephrine."

Establishes that exogenous catecholamine administration can itself cause the syndrome, which is the mechanistic basis for avoiding it as therapy.

Cardiac rehabilitation

Action: cardiac rehabilitation Ontology label: Cardiac Rehabilitation NCIT:C101234

Platform: Behavioral / lifestyle

Structured exercise-based rehabilitation addresses the part of the illness that ejection fraction recovery does not: the persistent exercise intolerance, fatigue, and autonomic dysfunction of the chronic subclinical phase. It is one of the few interventions aimed at the enduring vulnerability rather than the acute event.

Mechanism Target:

MODULATES Persistent subclinical myocardial dysfunction — Exercise training targets the residual functional impairment and autonomic dysregulation that outlast recovery of ejection fraction.

Show evidence (1 reference)

PMID:35344411 SUPPORT Human Clinical

"many continue to have limiting symptoms despite restoration of left ventricular ejection fraction"

Establishes the residual symptomatic target of rehabilitation; PARTIAL because the review documents the unmet need rather than the efficacy of rehabilitation against it.

Show evidence (1 reference)

PMID:35344411 SUPPORT Human Clinical

"there is a lack of evidence-based interventions to treat the acute episode, to avoid recurrences, and to prevent major adverse cardiovascular events"

Places rehabilitation in a field with no proven disease-modifying therapy; PARTIAL because it characterises the evidence vacuum rather than supporting this intervention.

Psychological therapy and stress management

Action: psychotherapy Ontology label: Psychotherapy NCIT:C15308

Platform: Behavioral / lifestyle

Given the trigger structure and the high burden of comorbid anxiety and mood disorder, psychological intervention is a rational secondary-prevention strategy and is under active investigation. It is not supported by outcome trials, and is curated here as a rationally targeted rather than an evidence-proven treatment.

Mechanism Target:

MODULATES Acute emotional or physical stressor — Reducing stress reactivity is intended to lower the probability that a future stressor precipitates a recurrence.

Show evidence (1 reference)

PMID:26332547 SUPPORT Human Clinical

"rates of neurologic or psychiatric disorders were higher (55.8% vs. 25.7%)"

Establishes the psychiatric comorbidity that the intervention targets; PARTIAL because the registry documents the association and not the effect of treating it.

Show evidence (1 reference)

PMID:30831580 SUPPORT INDIRECT Human Clinical

"Severe activation of the sympathetic nervous system with catecholamine release caused by a dysfunctional limbic system has been proposed as a potential mechanism."

Supplies the brain-level rationale for a psychological intervention; INDIRECT because it is a proposed mechanism, not evidence for the therapy.

🔬

Biochemical Markers

4

Plasma epinephrine (INCREASED)

Pathograph Readouts

Readout Of Sympathoadrenal activation and catecholamine surge

Plasma epinephrine is a direct measurement of the sympathoadrenal catecholamine surge node.

Show evidence (1 reference)

PMID:15703419 SUPPORT Human Clinical

"Plasma catecholamine levels at presentation were markedly higher among patients with stress-induced cardiomyopathy than among those with Killip class III myocardial infarction"

The comparison against a haemodynamically matched control condition.

Show evidence (1 reference)

PMID:15703419 SUPPORT Human Clinical

"Plasma catecholamine levels at presentation were markedly higher among patients with stress-induced cardiomyopathy than among those with Killip class III myocardial infarction"

The comparison against a haemodynamically matched control condition.

Plasma norepinephrine (INCREASED)

Pathograph Readouts

Readout Of Sympathoadrenal activation and catecholamine surge

Plasma norepinephrine is a direct measurement of the sympathoadrenal catecholamine surge node, alongside epinephrine.

Show evidence (1 reference)

PMID:15703419 SUPPORT Human Clinical

"Plasma catecholamine levels at presentation were markedly higher among patients with stress-induced cardiomyopathy than among those with Killip class III myocardial infarction"

The comparison against a haemodynamically matched control condition, reported for plasma catecholamines generally, which includes norepinephrine.

Show evidence (1 reference)

PMID:22732314 SUPPORT Model Organism

"a high intravenous epinephrine, but not norepinephrine, bolus produces the characteristic reversible apical depression of myocardial contraction"

Distinguishes the two catecholamines mechanistically, which is why they are curated separately.

Interleukin-6 (INCREASED)

Pathograph Readouts

Readout Of Myocardial macrophage inflammatory infiltrate

Serum interleukin-6 is the circulating cytokine correlate of the myocardial and systemic macrophage-driven inflammatory response.

Show evidence (1 reference)

PMID:30586731 SUPPORT Human Clinical

"Serum interleukin-6 (23.1±4.5 pg/mL versus 6.5±5.8 pg/mL; P<0.001) and chemokine (C-X-C motif) ligand 1 (1903±168 pg/mL versus 1272±177 pg/mL; P=0.01) concentrations and classic CD14++CD16- monocytes (90±0.5% versus 87±0.9%; P=0.01) were also increased"

Reports the interleukin-6 rise alongside the monocyte-subset shift in the same cohort as the macrophage infiltrate finding.

Show evidence (1 reference)

PMID:30586731 SUPPORT Human Clinical

"Serum interleukin-6 (23.1±4.5 pg/mL versus 6.5±5.8 pg/mL; P<0.001)"

Quantifies the acute elevation against matched controls.

Brain natriuretic peptide (INCREASED)

Pathograph Readouts

Readout Of Acute left ventricular systolic dysfunction

Circulating brain natriuretic peptide reflects the ventricular wall stress produced by the acute systolic impairment, disproportionately to troponin.

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"Takotsubo syndrome is frequently associated with a substantial increase in the plasma levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) reaching its peak approximately 24–48 h after symptom onset"

States the substantial rise in plasma B-type natriuretic peptide that this marker records.

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"Takotsubo syndrome is frequently associated with a substantial increase in the plasma levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) reaching its peak approximately 24–48 h after symptom onset"

States the substantial rise in plasma B-type natriuretic peptide that this marker records.

🔬

Diagnosis

6

Coronary angiography and left ventriculography

Performed in essentially every case, because the presentation is indistinguishable from acute coronary syndrome and the diagnosis is partly one of exclusion. Ventriculography at the same sitting demonstrates the circumferential wall-motion abnormality and permits direct measurement of an outflow tract gradient on pigtail pullback.

coronary angiography NCIT:C100085

Show evidence (1 reference)

PMID:15703419 SUPPORT Human Clinical

"All patients underwent coronary angiography and serial echocardiography"

Angiography is the mandatory step that excludes the condition being mimicked.

Transthoracic echocardiography

First-line and serial imaging: it identifies the regional wall-motion abnormality, detects and quantifies a dynamic outflow gradient and systolic anterior motion of the mitral valve, and documents recovery. Speckle-tracking strain may stay abnormal after ejection fraction has normalised.

echocardiography NCIT:C16525

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"a pressure gradient can be detected and quantified using Doppler echocardiography using continuous wave Doppler"

Consensus statement of echocardiography's specific role in detecting the outflow obstruction that alters management.

Electrocardiography

Shows diffuse ST elevation early, then deep diffuse T-wave inversion and QTc prolongation. The ECG cannot distinguish takotsubo from anterior infarction at presentation, which is precisely why angiography is mandatory, but serial tracings are informative and QTc guides arrhythmic risk and drug choice.

electrocardiography NCIT:C38053

Show evidence (1 reference)

PMID:15703419 SUPPORT Human Clinical

"Diffuse T-wave inversion and a prolonged QT interval occurred in most patients."

The electrocardiographic findings the test is performed to detect.

Cardiac magnetic resonance imaging

The decisive adjunct when the diagnosis is uncertain. Takotsubo shows regional oedema without the ischaemic late gadolinium enhancement pattern of infarction and without the subepicardial pattern of myocarditis. Imaging is most informative within the first week. Iron-oxide-enhanced protocols additionally reveal the macrophage infiltrate, though that remains a research technique.

magnetic resonance imaging NCIT:C16809

Show evidence (1 reference)

PMID:30586731 SUPPORT Human Clinical

"patients with takotsubo cardiomyopathy underwent multiparametric cardiac magnetic resonance imaging, including ultrasmall superparamagnetic particles of iron oxide (USPIO) enhancement for detection of inflammatory macrophages in the myocardium"

Documents the multiparametric cardiac magnetic resonance protocol and its tissue-characterisation capability.

Cardiac troponin measurement

Troponin is measured to establish myocardial injury and, more usefully, to quantify how small it is relative to the extent of dysfunction. A troponin proportionate to a large akinetic territory argues for infarction instead.

troponin measurement NCIT:C111327

Show evidence (1 reference)

PMID:15703419 SUPPORT Human Clinical

"Seventeen patients had mildly elevated serum troponin I levels, but only 1 of 19 had angiographic evidence of clinically significant coronary disease."

Shows the troponin-to-coronary-anatomy mismatch that the measurement is used to detect.

Natriuretic peptide measurement

B-type natriuretic peptide or its N-terminal prohormone is markedly elevated, out of proportion to the troponin, and the ratio between them is a core discriminator built into the InterTAK diagnostic score.

brain natriuretic peptide measurement NCIT:C74735

Show evidence (1 reference)

PMID:29850820 SUPPORT Human Clinical

"Takotsubo syndrome is frequently associated with a substantial increase in the plasma levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) reaching its peak approximately 24–48 h after symptom onset"

States the substantial elevation the measurement is performed to detect, and its time course.

📈

Progression

3

Acute phase

The first 24 to 72 hours, when the wall-motion abnormality is maximal and the risk of cardiogenic shock, outflow obstruction, and malignant arrhythmia is concentrated. This is also the window in which the diagnosis is usually made, by angiography excluding obstructive disease in a patient whose ventriculogram shows circumferential akinesis.

Show evidence (1 reference)

PMID:26332547 SUPPORT Human Clinical

"Rates of severe in-hospital complications including shock and death were similar in the two groups"

Establishes that acute-phase risk matches that of acute coronary syndrome rather than being benign.

Recovery phase

Over the following two to four weeks ejection fraction normalises in the great majority. Recovery is spontaneous; no therapy has been shown to accelerate it.

Show evidence (1 reference)

PMID:15703419 SUPPORT Human Clinical

"rapidly resolved in all patients"

Documents complete recovery of systolic function in every patient in the defining series.

Chronic subclinical phase

After ejection fraction normalises, a substantial fraction of survivors retain abnormal strain and impaired myocardial energetics, remain symptomatic, and carry a long-term event rate approaching that of acute coronary syndrome survivors. Recurrence affects roughly four to ten percent, often in a different ballooning pattern.

Show evidence (1 reference)

PMID:35344411 SUPPORT Human Clinical

"patients with takotsubo syndrome have persistent subtle ongoing cardiac dysfunction, and many continue to have limiting symptoms despite restoration of left ventricular ejection fraction"

Defines the chronic subclinical phase and its symptomatic burden.

📊

Prevalence

2

Hospitalised adults, United States

Point Prevalence Rare

199 890 admissions carrying a takotsubo diagnosis were identified in the Nationwide Inpatient Sample over 2016 to 2020, with a strong female predominance. The syndrome accounts for roughly one to three percent of presentations that initially look like acute coronary syndrome.

Show evidence (1 reference)

PMID:40365782 SUPPORT Human Clinical

"A total of 199 890 patients with Takotsubo were found in our database with 83% being female and higher prevalence with age, White race, and highest income."

National inpatient denominator and the demographic distribution.

International Takotsubo Registry

Cases In Literature Rare

Nearly 90 percent of registry patients are women, with a mean age in the late sixties, the demographic signature that any mechanistic account has to explain.

Show evidence (1 reference)

PMID:26332547 SUPPORT Human Clinical

"Of 1750 patients with takotsubo cardiomyopathy, 89.8% were women (mean age, 66.8 years)."

The registry demographic that defines the at-risk population.

⚖️

Clinical Burden

High

In-hospital mortality is around 6.5 percent and is not falling, which is comparable to acute myocardial infarction and refutes the historical description of the syndrome as benign. More than a third of admitted patients develop congestive heart failure, one in five atrial fibrillation, and one in fifteen cardiogenic shock. Men are a small minority of cases but die at more than twice the rate of women, for reasons that are unexplained.

The burden is not confined to the admission. Survivors commonly remain fatigued, breathless, and exercise-limited after ejection fraction has normalised, and their long-term major adverse cardiovascular event rate approaches that of acute coronary syndrome survivors. Recurrence affects roughly four to ten percent. No therapy has been shown in a randomised trial to alter any of this.

Show evidence (3 references)

PMID:40365782 SUPPORT Human Clinical

"Mortality was high at 6.5% with no significant improvement over the years studied."

National inpatient mortality with an explicit statement that it is not falling.

PMID:40365782 SUPPORT Human Clinical

"Mortality was more than double in men in comparison to women (11.2% versus 5.5%)."

Quantifies the unexplained sex disparity in a national cohort.

PMID:35344411 SUPPORT Human Clinical

"many continue to have limiting symptoms despite restoration of left ventricular ejection fraction"

Documents the residual symptomatic burden that the recovered ejection fraction conceals.

🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from Takotsubo Cardiomyopathy:

Acute myocardial infarction

Overlapping Features The condition takotsubo mimics and the reason angiography is mandatory. Distinguishing features are a wall-motion abnormality that crosses coronary territories, unobstructed epicardial arteries, a troponin too small for the territory involved, a natriuretic peptide too large for the troponin, and complete recovery of function.

Show evidence (1 reference)

PMID:33602474 SUPPORT Human Clinical

"TTS is now routinely diagnosed in patients who present with acute chest pain, electrocardiographic changes, troponin elevation, unobstructed coronary arteries, and a typical pattern of circumferential left ventricular wall motion abnormalities"

States the discriminating combination of unobstructed arteries with a circumferential abnormality.

Acute myocarditis

Overlapping Features Also presents with chest pain, troponin release, and unobstructed coronaries. Cardiac magnetic resonance separates them: myocarditis shows subepicardial or midmyocardial late gadolinium enhancement, whereas takotsubo shows oedema without that ischaemic or inflammatory scar pattern.

Show evidence (1 reference)

PMID:30586731 SUPPORT Human Clinical

"patients with takotsubo cardiomyopathy underwent multiparametric cardiac magnetic resonance imaging"

Establishes multiparametric cardiac magnetic resonance as the tissue-characterisation tool used to separate the two; PARTIAL because the study is not a diagnostic-accuracy comparison against myocarditis.

Pheochromocytoma crisis

Overlapping Features Produces an essentially identical catecholamine cardiomyopathy, with the same contraction-band histology, from an endogenous tumour source rather than a stress response. It matters because it is treatable and recurrent if missed, and because it is strong independent evidence that the catecholamine mechanism is causal.

Show evidence (1 reference)

PMID:22732314 SUPPORT Model Organism

"It is precipitated by extreme stress and can be triggered by intravenous catecholamine administration, particularly epinephrine."

Establishes that a pure catecholamine exposure reproduces the syndrome, which is the shared mechanism with pheochromocytoma; PARTIAL because the source addresses exogenous rather than tumour-derived catecholamine.

{ }

Source YAML

click to show

name: Takotsubo Cardiomyopathy
creation_date: '2026-08-09T00:00:00Z'
category: Complex
description: >
  Takotsubo cardiomyopathy is an acute, largely reversible heart failure syndrome in which
  an emotional or physical stressor precipitates severe regional left ventricular
  dysfunction in the absence of obstructive coronary disease sufficient to explain it. The
  wall-motion abnormality is circumferential and crosses coronary territories, most often
  ballooning the apex while the base contracts vigorously, which is the feature that
  separates it from infarction and gives the syndrome its name. Presentation is
  indistinguishable from acute coronary syndrome at the bedside: chest pain, ST-segment
  elevation, and troponin release. The mechanism is catecholamine-driven, and the leading
  molecular account is a concentration-dependent switch of beta2-adrenergic receptor
  coupling from stimulatory Gs to inhibitory Gi, which converts a positive inotropic
  signal into a negative one precisely where beta2-receptor density is highest. Direct
  catecholamine cardiotoxicity, coronary microvascular dysfunction, a macrophage
  inflammatory infiltrate, and altered central limbic-autonomic processing all contribute,
  and no single one explains the whole picture. Ejection fraction usually normalises within
  weeks, but the syndrome is not benign: in-hospital mortality is comparable to myocardial
  infarction, subclinical dysfunction persists in many survivors, and no treatment has been
  shown in randomised trials to alter the course.
disease_term:
  preferred_term: Takotsubo cardiomyopathy
  term:
    id: MONDO:0019018
    label: Tako-tsubo cardiomyopathy
parents:
- Cardiomyopathy
synonyms:
- Takotsubo syndrome
- Stress cardiomyopathy
- Stress-induced cardiomyopathy
- Apical ballooning syndrome
- Broken heart syndrome
- Ampulla cardiomyopathy
- Transient left ventricular apical ballooning syndrome
pathophysiology:
- name: Acute emotional or physical stressor
  description: >
    The initiating event is an acute stressor: bereavement, fear, anger, or interpersonal
    conflict on the emotional side; surgery, sepsis, respiratory failure, seizure,
    intracranial haemorrhage, or trauma on the physical side. Contemporary registry data
    overturned the original "broken heart" framing by showing that physical triggers are
    at least as common as emotional ones, and that patients with physical or neurologic
    triggers do worse. A minority of cases have no identifiable trigger at all, which is
    itself an argument against a purely reactive model.
  biological_scale: ORGANISM
  role: trigger
  downstream:
  - target: Sympathoadrenal activation and catecholamine surge
    causal_link_type: DIRECT
    description: >
      The stressor activates the sympathetic nervous system and adrenal medulla, releasing
      catecholamines into the circulation and from cardiac sympathetic nerve terminals.
    evidence:
    - reference: PMID:15703419
      reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Emotional stress can precipitate severe, reversible left ventricular dysfunction in patients without coronary disease. Exaggerated sympathetic stimulation is probably central to the cause of this syndrome."
      explanation: Establishes the stressor-to-sympathetic-surge link as the causal chain's first step, in the study that defined it.
  evidence:
  - reference: PMID:26332547
    reference_title: "Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Emotional triggers were not as common as physical triggers"
    explanation: International Takotsubo Registry finding in 1750 patients that reversed the prior assumption that emotional stress dominates.
  - reference: PMID:15703419
    reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We evaluated 19 patients who presented with left ventricular dysfunction after sudden emotional stress."
    explanation: The defining case series, in which the emotional stressor is the enrolment criterion.
- name: Sympathoadrenal activation and catecholamine surge
  description: >
    Plasma epinephrine, norepinephrine, and dopamine rise steeply, to levels several-fold
    above those measured in patients with severe myocardial infarction and pulmonary
    oedema. The comparison matters: it is not simply that catecholamines are elevated in a
    sick patient, but that they are elevated far beyond what comparable haemodynamic
    stress produces. Endogenous catecholamine excess from pheochromocytoma, and iatrogenic
    epinephrine administration, reproduce the syndrome, which is the strongest available
    argument that the surge is causal rather than reactive.
  biological_scale: ORGANISM
  role: mechanism
  biological_processes:
  - preferred_term: cellular response to catecholamine stimulus
    term:
      id: GO:0071870
      label: cellular response to catecholamine stimulus
    modifier: INCREASED
  cell_types:
  - preferred_term: Adrenal medullary chromaffin cell
    term:
      id: CL:0000166
      label: chromaffin cell
  downstream:
  - target: Beta2-adrenergic receptor switch from Gs to Gi coupling
    causal_link_type: DIRECT
    description: >
      Supraphysiologic epinephrine concentrations drive the beta2-adrenergic receptor into
      inhibitory G-protein coupling.
    evidence:
    - reference: PMID:22732314
      reference_title: "High levels of circulating epinephrine trigger apical cardiodepression in a beta2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "We describe an in vivo rat model in which a high intravenous epinephrine, but not norepinephrine, bolus produces the characteristic reversible apical depression of myocardial contraction coupled with basal hypercontractility."
      explanation: Shows a high epinephrine bolus is sufficient to produce the takotsubo contraction pattern, and that norepinephrine is not, implicating the epinephrine-preferring beta2 receptor.
  - target: Cardiomyocyte calcium overload and oxidative stress
    causal_link_type: DIRECT
    description: >
      Sustained adrenergic overstimulation of cardiomyocytes drives intracellular calcium
      loading and reactive oxygen species generation.
    evidence:
    - reference: PMID:33602474
      reference_title: "Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "including review of the evidence for microvascular dysfunction, myocardial beta-adrenergic signaling, inflammation, and electrophysiology"
      explanation: Names beta-adrenergic signalling on the myocardium as one of the established mechanistic arms; PARTIAL because the review abstract enumerates the arms rather than demonstrating the calcium step.
  - target: Coronary microvascular dysfunction
    causal_link_type: DIRECT
    description: >
      Catecholamine excess constricts and impairs the coronary microcirculation.
    evidence:
    - reference: PMID:33602474
      reference_title: "Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "including review of the evidence for microvascular dysfunction, myocardial beta-adrenergic signaling, inflammation, and electrophysiology"
      explanation: Lists microvascular dysfunction as an evidenced mechanistic arm alongside adrenergic signalling; PARTIAL because the abstract asserts the arm exists rather than the specific catecholamine-to-microvessel edge.
  evidence:
  - reference: PMID:15703419
    reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Plasma catecholamine levels at presentation were markedly higher among patients with stress-induced cardiomyopathy than among those with Killip class III myocardial infarction"
    explanation: The comparison that makes the surge specific to the syndrome rather than to critical illness generally.
- name: Beta2-adrenergic receptor switch from Gs to Gi coupling
  description: >
    The leading molecular explanation for why the apex fails while the base becomes
    hypercontractile. At physiologic epinephrine levels the beta2-adrenergic receptor
    couples to stimulatory Gs and is inotropic. At the supraphysiologic levels reached in
    a catecholamine surge the receptor switches to inhibitory Gi, converting the same
    ligand into a negative inotropic and cardioprotective signal. Because beta2-receptor
    density and responsiveness are highest in apical cardiomyocytes, the switch is
    expressed as regional apical cardiodepression. Blocking Gi with pertussis toxin
    abolishes the apical depression, which is the causal test.
  biological_scale: MOLECULAR
  role: mechanism
  molecular_functions:
  - preferred_term: beta2-adrenergic receptor activity
    term:
      id: GO:0004941
      label: beta2-adrenergic receptor activity
    modifier: GAIN_OF_FUNCTION
  biological_processes:
  - preferred_term: adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
    term:
      id: GO:0007193
      label: adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
    modifier: INCREASED
  cell_types:
  - preferred_term: Apical cardiomyocyte
    term:
      id: CL:0000746
      label: cardiac muscle cell
  locations:
  - preferred_term: Left ventricle
    term:
      id: UBERON:0002084
      label: heart left ventricle
  downstream:
  - target: Reversible regional wall motion abnormality
    causal_link_type: DIRECT
    description: >
      Negative inotropy confined to the beta2-receptor-rich apex produces apical akinesis
      with preserved or exaggerated basal contraction.
    evidence:
    - reference: PMID:22732314
      reference_title: "High levels of circulating epinephrine trigger apical cardiodepression in a beta2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "β(2)AR number and functional responses were greater in isolated apical cardiomyocytes than in basal cardiomyocytes, which confirmed the higher apical sensitivity and response to circulating epinephrine."
      explanation: Supplies the regional gradient that converts a systemic hormonal signal into a regional contractile defect.
  evidence:
  - reference: PMID:22732314
    reference_title: "High levels of circulating epinephrine trigger apical cardiodepression in a beta2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "The effect is prevented via G(i) inactivation by pertussis toxin pretreatment."
    explanation: The interventional test, in which removing Gi signalling removes the apical depression, establishing the switch as causal rather than correlated.
  - reference: PMID:22732314
    reference_title: "High levels of circulating epinephrine trigger apical cardiodepression in a beta2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "In vitro studies demonstrated high-dose epinephrine can induce direct cardiomyocyte cardiodepression and cardioprotection in a β(2)AR-Gi-dependent manner."
    explanation: Shows the switch operates at the level of the isolated cardiomyocyte, independent of vascular or neural intermediaries.
- name: Cardiomyocyte calcium overload and oxidative stress
  description: >
    Beta-adrenergic overstimulation loads the cardiomyocyte with calcium, generates
    reactive oxygen species, and impairs mitochondrial energetics. This is the classical
    catecholamine cardiotoxicity mechanism, shared with pheochromocytoma crisis and
    subarachnoid haemorrhage, and it is what produces the histologic lesion below. It is a
    parallel arm to the receptor switch rather than a consequence of it: the switch
    explains the regional distribution, this explains the tissue injury.
  biological_scale: CELLULAR
  role: mechanism
  cell_types:
  - preferred_term: Cardiomyocyte
    term:
      id: CL:0000746
      label: cardiac muscle cell
  biological_processes:
  - preferred_term: intracellular calcium ion homeostasis
    term:
      id: GO:0006874
      label: intracellular calcium ion homeostasis
    modifier: ABNORMAL
  - preferred_term: response to oxidative stress
    term:
      id: GO:0006979
      label: response to oxidative stress
    modifier: INCREASED
  downstream:
  - target: Contraction band necrosis and focal myocytolysis
    causal_link_type: DIRECT
    description: >
      Calcium overload drives hypercontraction of sarcomeres, producing the contraction
      band lesion.
    evidence:
    - reference: PMID:15703419
      reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Endomyocardial biopsy showed mononuclear infiltrates and contraction-band necrosis."
      explanation: Human tissue confirmation that the injury is the calcium-overload contraction band lesion, not ischaemic coagulative necrosis.
  evidence:
  - reference: PMID:35344411
    reference_title: "Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Catecholamine-induced myocardial injury is the most established and well-known theory, but this does not explain all the clinical features and presentations of the condition, and numerous other pathways and abnormalities are emerging."
    explanation: States catecholamine cardiotoxicity as the best-established mechanism while explicitly flagging it as incomplete, which is why this node sits parallel to the others rather than upstream of them.
- name: Contraction band necrosis and focal myocytolysis
  description: >
    The histologic signature, seen on endomyocardial biopsy: hypercontracted sarcomeres
    with dense eosinophilic transverse bands, focal myocyte dropout, and a mononuclear
    rather than neutrophilic infiltrate. It is qualitatively different from the coagulative
    necrosis of infarction, and it is reversible, which is the tissue-level reason the
    ventricle recovers. The same lesion appears in pheochromocytoma and in neurogenic
    stunned myocardium, tying the three catecholamine-excess states together.
  biological_scale: TISSUE
  role: consequence
  locations:
  - preferred_term: Left ventricular myocardium
    term:
      id: UBERON:0006566
      label: left ventricle myocardium
  downstream:
  - target: Myocardial macrophage inflammatory infiltrate
    causal_link_type: DIRECT
    description: >
      Injured and dying myocytes recruit macrophages into the myocardium.
    evidence:
    - reference: PMID:30586731
      reference_title: "Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "We demonstrate for the first time that takotsubo cardiomyopathy is characterized by a myocardial macrophage inflammatory infiltrate, changes in the distribution of monocyte subsets, and an increase in systemic proinflammatory cytokines."
      explanation: Establishes the macrophage infiltrate in vivo by iron-oxide-enhanced cardiac magnetic resonance, in a matched-control study.
  evidence:
  - reference: PMID:15703419
    reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Endomyocardial biopsy showed mononuclear infiltrates and contraction-band necrosis."
    explanation: Direct human histology from the defining case series.
- name: Coronary microvascular dysfunction
  description: >
    Coronary flow reserve is impaired and microcirculatory resistance is elevated in the
    acute phase despite angiographically unobstructed epicardial arteries. Whether this is
    a primary driver of the stunning or a consequence of the same catecholamine surge acting
    on the microvasculature is unresolved, and the alpha-adrenergic receptors that dominate
    the coronary microcirculation are one proposed reason beta-blockade alone fails to
    prevent recurrence.
  biological_scale: TISSUE
  role: mechanism
  cell_types:
  - preferred_term: Cardiac endothelial cell
    term:
      id: CL:0010008
      label: cardiac endothelial cell
  downstream:
  - target: Reversible regional wall motion abnormality
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >
      Regional hypoperfusion from microvascular constriction contributes to the regional
      contractile failure, additively with the receptor switch.
    evidence:
    - reference: PMID:33602474
      reference_title: "Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "including review of the evidence for microvascular dysfunction, myocardial beta-adrenergic signaling, inflammation, and electrophysiology"
      explanation: The state-of-the-art review treats microvascular dysfunction as an evidenced contributor to the wall-motion abnormality; PARTIAL because its relative causal weight is explicitly unsettled.
  - target: Chest pain
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >
      Microvascular ischaemia, alongside the acute regional contractile failure it
      contributes to, is the proposed substrate for anginal chest pain in a patient with
      unobstructed epicardial arteries.
    evidence:
    - reference: PMID:33602474
      reference_title: "Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: "including review of the evidence for microvascular dysfunction, myocardial beta-adrenergic signaling, inflammation, and electrophysiology"
      explanation: Names microvascular dysfunction as an evidenced mechanistic arm. The support is indirect, since the abstract enumerates the arm rather than tracing it specifically to the pain symptom.
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "suggesting that other receptors such as alpha-receptors, that are more prevalent in the coronary microcirculation, might be involved"
    explanation: The consensus statement's own inference from beta-blocker failure, pointing at alpha-adrenergic control of the coronary microcirculation; PARTIAL because it is an inference offered as hypothesis.
- name: Myocardial macrophage inflammatory infiltrate
  description: >
    Iron-oxide-enhanced cardiac magnetic resonance shows macrophage accumulation in both
    ballooning and non-ballooning left ventricular segments, accompanied by a shift in
    circulating monocyte subsets and raised interleukin-6 and CXCL1. Two findings make this
    more than an epiphenomenon of injury. First, the infiltrate is present in segments that
    are contracting normally, so it is not simply a reaction to regional akinesis. Second,
    the systemic inflammatory changes persist for months after the myocardial signal has
    resolved, which is the best current mechanistic candidate for the persistent subclinical
    dysfunction seen in survivors.
  biological_scale: TISSUE
  role: mechanism
  cell_types:
  - preferred_term: Cardiac macrophage
    term:
      id: CL:0000235
      label: macrophage
  - preferred_term: Classical monocyte
    term:
      id: CL:0000576
      label: monocyte
  biological_processes:
  - preferred_term: inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
    modifier: INCREASED
  downstream:
  - target: Persistent subclinical myocardial dysfunction
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >
      A low-grade chronic inflammatory state outlasting the acute event is the proposed
      substrate for continuing symptoms after ejection fraction recovers.
    evidence:
    - reference: PMID:30586731
      reference_title: "Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Many of these changes persisted for at least 5 months, suggesting a low-grade chronic inflammatory state."
      explanation: Documents persistence of the systemic inflammatory changes well beyond the acute episode.
  evidence:
  - reference: PMID:30586731
    reference_title: "Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "patients with takotsubo cardiomyopathy had greater USPIO enhancement (expressed as the difference between pre-USPIO and post-USPIO T2*) in both ballooning"
    explanation: Shows the macrophage signal is present in ballooning segments; the same sentence continues to report it in non-ballooning segments too.
  - reference: PMID:30586731
    reference_title: "Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Serum interleukin-6 (23.1±4.5 pg/mL versus 6.5±5.8 pg/mL; P<0.001) and chemokine (C-X-C motif) ligand 1 (1903±168 pg/mL versus 1272±177 pg/mL; P=0.01) concentrations and classic CD14++CD16- monocytes (90±0.5% versus 87±0.9%; P=0.01) were also increased"
    explanation: Quantifies the systemic inflammatory arm against matched controls.
- name: Central limbic and autonomic network hypoconnectivity
  description: >
    Resting-state functional magnetic resonance imaging in takotsubo survivors shows
    reduced connectivity in both sympathetic- and parasympathetic-associated subnetworks,
    involving amygdala, hippocampus, insula, and cingulate cortex. The direction of
    causation is the open question and is curated as such: these are the regions that
    generate and regulate the autonomic outflow, so reduced integration is a plausible
    predisposing lesion, but the imaging is done after the cardiac event, so it is equally
    compatible with the event having altered the brain.
  biological_scale: ORGANISM
  role: mechanism
  downstream:
  - target: Sympathoadrenal activation and catecholamine surge
    causal_link_type: DIRECT
    description: >
      Impaired central autonomic integration is proposed to permit an unrestrained
      sympathetic discharge in response to a stressor.
    evidence:
    - reference: PMID:30831580
      reference_title: "Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Severe activation of the sympathetic nervous system with catecholamine release caused by a dysfunctional limbic system has been proposed as a potential mechanism."
      explanation: States the proposed brain-to-heart edge; PARTIAL because the study demonstrates the connectivity abnormality and not the temporal direction.
  evidence:
  - reference: PMID:30831580
    reference_title: "Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We found parasympathetic- and sympathetic-associated subnetworks both showing reduced resting state functional connectivity in TTS patients compared with controls."
    explanation: The primary finding, in 15 takotsubo patients against 39 healthy controls.
  - reference: PMID:30831580
    reference_title: "Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Important brain regions constituting parasympathetic- and sympathetic-associated subnetworks included the amygdala, hippocampus, and insula as well as cingulate, parietal, temporal, and cerebellar regions."
    explanation: Localises the abnormality to the limbic-autonomic regions that generate sympathetic outflow.
- name: Reversible regional wall motion abnormality
  description: >
    The defining lesion: a circumferential regional wall-motion abnormality that extends
    beyond the territory of any single epicardial coronary artery. The apical-ballooning
    variant, with akinetic apex and hypercontractile base, is the commonest, but
    mid-ventricular, basal ("reverse"), and focal variants exist and a patient who recurs
    often does so in a different pattern. The circumferential distribution is what makes
    the diagnosis at ventriculography, because no coronary occlusion produces it.
  biological_scale: TISSUE
  role: consequence
  locations:
  - preferred_term: Left ventricle
    term:
      id: UBERON:0002084
      label: heart left ventricle
  downstream:
  - target: Acute left ventricular systolic dysfunction
    causal_link_type: DIRECT
    description: >
      Loss of contraction over a large contiguous territory drops global ejection fraction.
    evidence:
    - reference: PMID:15703419
      reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Severe left ventricular dysfunction was present on admission"
      explanation: Documents that the regional abnormality translates into severe global systolic impairment at presentation.
  - target: Dynamic left ventricular outflow tract obstruction
    causal_link_type: DIRECT
    description: >
      Basal hypercontractility with an akinetic apex accelerates flow through a narrowed
      outflow tract and draws the mitral leaflet forward.
    evidence:
    - reference: PMID:29850820
      reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Takotsubo syndrome patients with cardiogenic shock, in particular those with apical ballooning should be promptly evaluated for the presence of LVOTO, which occurs in about 20% of cases."
      explanation: Ties outflow obstruction specifically to the apical-ballooning geometry and quantifies its frequency.
  - target: Left ventricular mural thrombus
    causal_link_type: DIRECT
    description: >
      Blood stagnating in the akinetic apical cavity forms thrombus.
    evidence:
    - reference: PMID:40365782
      reference_title: "High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Cardiogenic shock occurred in 6.6%, atrial fibrillation in 20.7%, cardiac arrest in 3.4%, congestive heart failure in 35.9%, and stroke in 5.3%."
      explanation: Quantifies the stroke rate that apical thrombus embolisation contributes to; PARTIAL because the database report does not separately attribute strokes to mural thrombus.
  evidence:
  - reference: PMID:33602474
    reference_title: "Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a typical pattern of circumferential left ventricular wall motion abnormalities that usually involve the apical and midventricular myocardium"
    explanation: Defines the circumferential, apical-predominant distribution that separates the lesion from infarction.
- name: Acute left ventricular systolic dysfunction
  description: >
    Ejection fraction at presentation is severely reduced, typically well below that of
    matched acute coronary syndrome patients, and drives the clinical syndrome of acute
    heart failure, pulmonary oedema, and in a minority cardiogenic shock. Recovery is the
    rule and is fast, usually complete within two to four weeks.
  biological_scale: ORGANISM
  role: consequence
  downstream:
  - target: Persistent subclinical myocardial dysfunction
    causal_link_type: DIRECT
    description: >
      Recovery of ejection fraction is not recovery of myocardial function; strain and
      energetic abnormalities outlast it.
    evidence:
    - reference: PMID:35344411
      reference_title: "Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "recent studies have confirmed that patients with takotsubo syndrome have persistent subtle ongoing cardiac dysfunction, and many continue to have limiting symptoms despite restoration of left ventricular ejection fraction"
      explanation: States the dissociation between recovered ejection fraction and recovered function explicitly.
  - target: Pulmonary edema
    causal_link_type: DIRECT
    description: >
      The abrupt fall in systolic function raises left atrial and pulmonary venous
      pressure, producing acute pulmonary congestion.
    evidence:
    - reference: PMID:15703419
      reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Clinical presentations included chest pain, pulmonary edema, and cardiogenic shock."
      explanation: Documents pulmonary oedema as a presenting manifestation alongside the systolic impairment.
  - target: Congestive heart failure
    causal_link_type: DIRECT
    description: >
      Acute systolic impairment over a large contiguous myocardial territory produces
      the clinical syndrome of acute heart failure, the commonest in-hospital
      complication.
    evidence:
    - reference: PMID:40365782
      reference_title: "High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "congestive heart failure in 35.9%"
      explanation: Frequency of the heart-failure complication from the national inpatient cohort.
  - target: Atrial fibrillation
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >
      Elevated filling pressures and atrial stretch from the acute fall in systolic
      function precipitate the commonest arrhythmic complication.
    evidence:
    - reference: PMID:40365782
      reference_title: "High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: "Cardiogenic shock occurred in 6.6%, atrial fibrillation in 20.7%, cardiac arrest in 3.4%, congestive heart failure in 35.9%, and stroke in 5.3%."
      explanation: Frequency of atrial fibrillation from the national inpatient cohort. The support is indirect, since the database report does not separately attribute the arrhythmia mechanism to atrial stretch.
  evidence:
  - reference: PMID:26332547
    reference_title: "Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the mean left ventricular ejection fraction was markedly lower (40.7±11.2% vs. 51.5±12.3%)"
    explanation: Registry comparison against age- and sex-matched acute coronary syndrome patients, showing the systolic impairment is more severe than in the condition it mimics.
  - reference: PMID:15703419
    reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "rapidly resolved in all patients"
    explanation: Establishes reversibility as the defining course.
- name: Dynamic left ventricular outflow tract obstruction
  description: >
    Present in roughly one in five patients and the single most important reason takotsubo
    is not managed like other acute heart failure. The obstruction is dynamic and
    preload-dependent, so inotropes and nitrates worsen it, and it is the mechanism by
    which standard heart-failure reflexes make a shocked takotsubo patient worse rather
    than better. It must be looked for before catecholamines are given, not after.
  biological_scale: ORGANISM
  role: consequence
  downstream:
  - target: Cardiogenic shock
    causal_link_type: DIRECT
    description: >
      Obstruction to ejection compounds the systolic failure and precipitates shock.
    evidence:
    - reference: PMID:29850820
      reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Takotsubo syndrome patients with cardiogenic shock, in particular those with apical ballooning should be promptly evaluated for the presence of LVOTO"
      explanation: The consensus recommendation exists because outflow obstruction is a treatable contributor to shock in this population.
  evidence:
  - reference: PMID:32473281
    reference_title: "Mechanical circulatory support for Takotsubo syndrome: a systematic review and meta-analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cardiogenic shock occurs in 10%-15% of patients with Takotsubo syndrome (TS)."
    explanation: Independent estimate of shock incidence, higher than the national inpatient figure elsewhere in this entry, and worth recording as a range rather than a single number.
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the administration of nitroglycerin in the presence of LVOTO has been found to worsen the pressure gradient and therefore should be avoided in this scenario"
    explanation: Documents the therapeutic trap that makes recognising the obstruction consequential.
- name: Left ventricular mural thrombus
  description: >
    Thrombus forms in the akinetic apex during the acute phase and is the principal
    cardioembolic source in a syndrome that is otherwise not thrombotic. Because the
    akinesis is temporary, so is the indication for anticoagulation, which is an unusual
    situation and a recognised source of both under- and over-treatment.
  biological_scale: TISSUE
  role: consequence
  locations:
  - preferred_term: Left ventricle
    term:
      id: UBERON:0002084
      label: heart left ventricle
  downstream:
  - target: Stroke
    causal_link_type: DIRECT
    description: >
      Apical thrombus embolises to the cerebral circulation.
    evidence:
    - reference: PMID:29850820
      reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Severe LV dysfunction with extended apical ballooning entails the risk of an LV thrombus and subsequent systemic embolism."
      explanation: States the apical-ballooning to thrombus to systemic embolism sequence directly, which is the edge curated here.
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "as well as thrombus formation within a dysfunctional LV apex"
    explanation: Documents thrombus forming specifically within the dysfunctional apex, which ties the thrombus to the regional akinesis rather than to a general prothrombotic state.
- name: Persistent subclinical myocardial dysfunction
  description: >
    The finding that most changed how the syndrome is regarded. Global longitudinal strain
    and cardiac energetic reserve remain abnormal after ejection fraction has normalised,
    survivors continue to report fatigue, dyspnoea, and exercise intolerance, and long-term
    major adverse cardiovascular event rates approach those after acute coronary syndrome.
    Takotsubo is therefore better described as an acute event on a background of enduring
    vulnerability than as a self-limited illness, which is also consistent with the four to
    ten percent recurrence rate.
  biological_scale: ORGANISM
  role: consequence
  downstream:
  - target: Anxiety
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >
      Ongoing subclinical cardiac limitation and enduring vulnerability are proposed to
      sustain psychological distress that commonly follows the acute event, alongside
      the pre-existing anxiety burden that predisposes to it in the first place; the
      direction between cardiac and psychiatric disease here is genuinely bidirectional.
    evidence:
    - reference: PMID:26332547
      reference_title: "Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: "rates of neurologic or psychiatric disorders were higher (55.8% vs. 25.7%)"
      explanation: Quantifies the excess psychiatric and neurologic burden in this population. The support is indirect, since the registry comparison does not itself separate pre-existing from event-triggered anxiety.
  evidence:
  - reference: PMID:35344411
    reference_title: "Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Moreover, these patients have a substantial burden of morbidity and mortality, as well, with high rates of subsequent major adverse cardiovascular events that approach those of patients with acute coronary syndrome."
    explanation: Quantifies the long-term consequence that contradicts the historical benign framing.
phenotypes:
- category: Symptom
  name: Chest pain
  description: >
    The commonest presenting complaint and the reason patients enter the acute coronary
    syndrome pathway. It is indistinguishable from ischaemic chest pain at the bedside.
  phenotype_term:
    preferred_term: Chest pain
    term:
      id: HP:0100749
      label: Chest pain
    temporality: ACUTE
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:15703419
    reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Clinical presentations included chest pain, pulmonary edema, and cardiogenic shock."
    explanation: Lists chest pain first among presenting features in the defining series.
- category: Symptom
  name: Dyspnea
  description: >
    Breathlessness from acute pulmonary congestion, and in some patients the sole presenting
    symptom, particularly when the syndrome arises during another acute illness.
  phenotype_term:
    preferred_term: Dyspnea
    term:
      id: HP:0002094
      label: Dyspnea
    temporality: ACUTE
  frequency: FREQUENT
  evidence:
  - reference: PMID:33602474
    reference_title: "Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "TTS is now routinely diagnosed in patients who present with acute chest pain, electrocardiographic changes, troponin elevation, unobstructed coronary arteries"
    explanation: Establishes the acute cardiorespiratory presentation; PARTIAL because dyspnoea is not itemised separately in the abstract.
- category: Clinical
  name: Pulmonary edema
  description: >
    Acute pulmonary congestion from the abrupt fall in systolic function, present at
    presentation in a substantial minority.
  phenotype_term:
    preferred_term: Pulmonary edema
    term:
      id: HP:0100598
      label: Pulmonary edema
    temporality: ACUTE
  sequelae:
  - target: Dyspnea
    causal_link_type: DIRECT
    description: >
      Acute pulmonary congestion is experienced as breathlessness.
    evidence:
    - reference: PMID:33602474
      reference_title: "Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: "TTS is now routinely diagnosed in patients who present with acute chest pain, electrocardiographic changes, troponin elevation, unobstructed coronary arteries"
      explanation: Establishes the acute cardiorespiratory presentation in which pulmonary congestion and breathlessness co-occur. The support is indirect, since dyspnoea is not itemised separately from the other presenting features.
  evidence:
  - reference: PMID:15703419
    reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Clinical presentations included chest pain, pulmonary edema, and cardiogenic shock."
    explanation: Documents pulmonary oedema as a presenting manifestation.
- category: Clinical
  name: ST segment elevation
  description: >
    Present at presentation in many patients and the reason the syndrome is routinely
    activated as a primary angioplasty call. Unlike infarction, the elevation is diffuse
    rather than confined to a coronary territory.
  phenotype_term:
    preferred_term: ST segment elevation
    term:
      id: HP:0012251
      label: ST segment elevation
    temporality: ACUTE
  reports_on:
  - target: Reversible regional wall motion abnormality
    relationship: READOUT_OF
    description: >
      Diffuse ST-segment elevation is the electrocardiographic correlate of the acute
      regional myocardial injury current over the ballooning segment.
    evidence:
    - reference: PMID:33602474
      reference_title: "Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: "a typical pattern of circumferential left ventricular wall motion abnormalities that usually involve the apical and midventricular myocardium"
      explanation: Defines the regional wall-motion lesion that the electrocardiographic changes track. The support is indirect, since the review states the imaging finding rather than the ECG-to-lesion correspondence explicitly.
  frequency: FREQUENT
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In the InterTAK Registry, ST-segment elevation was present in 44%, ST-segment depression in 8%, T-wave inversion in 41%, and left bundle branch block in 5%."
    explanation: Registry frequency supporting the FREQUENT band, and the reason this is not VERY_FREQUENT. ST elevation is present in fewer than half of patients, so an ECG without it does not argue against the diagnosis.
  - reference: PMID:15240400
    reference_title: "Emotional stress-induced Tako-tsubo cardiomyopathy: animal model and molecular mechanism."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "which is characterized by an elevation of the ST segment in the electrocardiogram (ECG) and left ventricular apical ballooning in the left ventriculogram (LVG)"
    explanation: Secondary support only. The publication reports a rat immobilisation-stress model, so it is tagged MODEL_ORGANISM; the quoted line is its introductory description of the human syndrome, which is why it is PARTIAL rather than primary evidence for a human phenotype.
- category: Clinical
  name: T-wave inversion
  description: >
    Deep, diffuse T-wave inversion typically develops over the first 24 to 48 hours and
    outlasts the ST changes, and is often the finding that raises the diagnosis in a
    patient whose angiogram was clean.
  phenotype_term:
    preferred_term: T-wave inversion
    term:
      id: HP:0010872
      label: T-wave inversion
    temporality: SUBACUTE
  reports_on:
  - target: Reversible regional wall motion abnormality
    relationship: READOUT_OF
    description: >
      Deep, diffuse repolarisation abnormality tracks the evolving injury of the
      recovering ballooning segment and outlasts the acute ST changes.
    evidence:
    - reference: PMID:33602474
      reference_title: "Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: "a typical pattern of circumferential left ventricular wall motion abnormalities that usually involve the apical and midventricular myocardium"
      explanation: Defines the regional wall-motion lesion that the electrocardiographic repolarisation changes track. The support is indirect, since the review states the imaging finding rather than the ECG-to-lesion correspondence explicitly.
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:15703419
    reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Diffuse T-wave inversion and a prolonged QT interval occurred in most patients."
    explanation: Documents both the finding and its frequency in the defining series.
- category: Clinical
  name: Prolonged QT interval
  description: >
    QT prolongation is near-universal in the acute phase and creates a real risk of
    pause-dependent torsade de pointes, which is why QT-prolonging drugs are avoided and
    magnesium is repleted.
  phenotype_term:
    preferred_term: Prolonged QT interval
    term:
      id: HP:0001657
      label: Prolonged QT interval
    temporality: ACUTE
  reports_on:
  - target: Sympathoadrenal activation and catecholamine surge
    relationship: READOUT_OF
    description: >
      The near-universal acute QT prolongation is an electrophysiological correlate of
      the catecholamine-driven myocardial injury and repolarisation disturbance.
    evidence:
    - reference: PMID:15703419
      reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: "Plasma catecholamine levels at presentation were markedly higher among patients with stress-induced cardiomyopathy than among those with Killip class III myocardial infarction"
      explanation: Establishes the catecholamine surge that accompanies the same acute phase in which QT prolongation is near-universal. The support is indirect, since the sentence documents the catecholamine level rather than the QT correlate specifically.
  sequelae:
  - target: Torsade de pointes
    causal_link_type: DIRECT
    description: >
      QT prolongation, particularly with bradycardia and a QTc above 500 ms, creates the
      pause-dependent substrate for torsade de pointes.
    evidence:
    - reference: PMID:29850820
      reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "due to the potential risk of pause-dependent torsades de pointes, beta-blockers should be used cautiously, especially in patients with bradycardia and QTc >500 ms"
      explanation: States the QT-to-torsade risk relationship directly, and the specific electrophysiologic context.
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:15703419
    reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Diffuse T-wave inversion and a prolonged QT interval occurred in most patients."
    explanation: Supports both the association and the "most patients" frequency band.
- category: Clinical
  name: Torsade de pointes
  description: >
    The arrhythmic complication that the QT prolongation creates, and the specific reason
    bradycardia and a QTc above 500 ms make beta-blockade hazardous rather than helpful in
    the acute phase.
  phenotype_term:
    preferred_term: Torsade de pointes
    term:
      id: HP:0001664
      label: Torsade de pointes
    temporality: ACUTE
  sequelae:
  - target: Cardiac arrest
    causal_link_type: DIRECT
    description: >
      Degeneration of torsade de pointes into a sustained malignant ventricular
      arrhythmia produces cardiac arrest.
    evidence:
    - reference: PMID:29850820
      reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Life-threatening ventricular arrhythmias, such as torsades de pointes, VT, or VF occur in 3.0–8.6% and are a frequent cause of death."
      explanation: Names torsade de pointes among the life-threatening ventricular arrhythmias that are a frequent cause of death in the syndrome.
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Life-threatening ventricular arrhythmias, such as torsades de pointes, VT, or VF occur in 3.0–8.6% and are a frequent cause of death."
    explanation: Gives the rate supporting the OCCASIONAL band, and states that these arrhythmias are a frequent cause of death, which is why QT management matters so much here.
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "due to the potential risk of pause-dependent torsades de pointes, beta-blockers should be used cautiously, especially in patients with bradycardia and QTc >500 ms"
    explanation: Names the arrhythmia and the electrophysiologic context in which it occurs.
- category: Clinical
  name: Reduced left ventricular ejection fraction
  description: >
    Severely reduced at presentation and lower than in matched acute coronary syndrome,
    then recovering over days to weeks. The combination of a very low ejection fraction with
    a modest troponin is one of the strongest bedside discriminators from infarction.
  phenotype_term:
    preferred_term: Reduced left ventricular ejection fraction
    term:
      id: HP:0012664
      label: Reduced left ventricular ejection fraction
    temporality: TRANSIENT
  reports_on:
  - target: Acute left ventricular systolic dysfunction
    relationship: READOUT_OF
    description: >
      The measured ejection fraction is the direct quantitative readout of the acute
      systolic dysfunction node.
    evidence:
    - reference: PMID:26332547
      reference_title: "Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "the mean left ventricular ejection fraction was markedly lower (40.7±11.2% vs. 51.5±12.3%)"
      explanation: Registry mean ejection fraction against matched acute coronary syndrome controls.
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:26332547
    reference_title: "Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the mean left ventricular ejection fraction was markedly lower (40.7±11.2% vs. 51.5±12.3%)"
    explanation: Registry mean ejection fraction against matched acute coronary syndrome controls.
- category: Clinical
  name: Regional left ventricular wall motion abnormality
  description: >
    The diagnostic lesion. Circumferential, crossing coronary territories, most often with
    an akinetic or dyskinetic apex and a hypercontractile base.
  phenotype_term:
    preferred_term: Regional left ventricular wall motion abnormality
    term:
      id: HP:0012667
      label: Regional left ventricular wall motion abnormality
    temporality: TRANSIENT
  reports_on:
  - target: Reversible regional wall motion abnormality
    relationship: READOUT_OF
    description: >
      This phenotype is the imaging observation of the pathophysiology node of the same
      underlying lesion: the circumferential, cross-territory regional contractile
      failure.
    evidence:
    - reference: PMID:33602474
      reference_title: "Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "a typical pattern of circumferential left ventricular wall motion abnormalities that usually involve the apical and midventricular myocardium"
      explanation: Describes the obligate imaging finding and its distribution.
  frequency: OBLIGATE
  evidence:
  - reference: PMID:33602474
    reference_title: "Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a typical pattern of circumferential left ventricular wall motion abnormalities that usually involve the apical and midventricular myocardium"
    explanation: Describes the obligate imaging finding and its distribution.
- category: Clinical
  name: Congestive heart failure
  description: >
    The commonest in-hospital complication, affecting more than a third of admitted
    patients in national inpatient data.
  phenotype_term:
    preferred_term: Congestive heart failure
    term:
      id: HP:0001635
      label: Congestive heart failure
    temporality: ACUTE
  frequency: FREQUENT
  evidence:
  - reference: PMID:40365782
    reference_title: "High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "congestive heart failure in 35.9%"
    explanation: Frequency from 199 890 admissions in the Nationwide Inpatient Sample, supporting the FREQUENT band.
- category: Clinical
  name: Atrial fibrillation
  description: >
    The commonest arrhythmic complication, occurring in about one patient in five.
  phenotype_term:
    preferred_term: Atrial fibrillation
    term:
      id: HP:0005110
      label: Atrial fibrillation
    temporality: ACUTE
  frequency: FREQUENT
  evidence:
  - reference: PMID:40365782
    reference_title: "High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cardiogenic shock occurred in 6.6%, atrial fibrillation in 20.7%, cardiac arrest in 3.4%, congestive heart failure in 35.9%, and stroke in 5.3%."
    explanation: Frequency from the national inpatient cohort, supporting the FREQUENT band.
- category: Clinical
  name: Cardiogenic shock
  description: >
    Occurs in roughly one in fifteen admitted patients and is the principal mode of early
    death. Outflow tract obstruction must be excluded before inotropes are started, because
    in that subgroup the standard reflex is actively harmful.
  phenotype_term:
    preferred_term: Cardiogenic shock
    term:
      id: HP:0030149
      label: Cardiogenic shock
    temporality: ACUTE
  sequelae:
  - target: Cardiac arrest
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >
      Refractory shock is, alongside malignant ventricular arrhythmia, one of the two
      recognised routes to cardiac arrest in this syndrome.
    evidence:
    - reference: PMID:40365782
      reference_title: "High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years."
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: "Cardiogenic shock occurred in 6.6%, atrial fibrillation in 20.7%, cardiac arrest in 3.4%, congestive heart failure in 35.9%, and stroke in 5.3%."
      explanation: Reports shock and cardiac arrest as co-occurring complications in the same inpatient cohort. The support is indirect, since the database report does not itself trace the causal step from shock to arrest.
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:40365782
    reference_title: "High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cardiogenic shock occurred in 6.6%"
    explanation: Frequency from the national inpatient cohort, supporting the OCCASIONAL band.
- category: Clinical
  name: Left ventricular outflow tract obstruction
  description: >
    Dynamic obstruction generated by the hypercontractile base, present in about a fifth of
    patients and decisive for management.
  phenotype_term:
    preferred_term: Left ventricular outflow tract obstruction
    term:
      id: HP:0032092
      label: Left ventricular outflow tract obstruction
    temporality: TRANSIENT
  reports_on:
  - target: Dynamic left ventricular outflow tract obstruction
    relationship: READOUT_OF
    description: >
      This phenotype is the echocardiographic/Doppler observation of the dynamic
      outflow-tract obstruction mechanism node.
    evidence:
    - reference: PMID:29850820
      reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "the presence of LVOTO, which occurs in about 20% of cases"
      explanation: Consensus-stated frequency supporting the FREQUENT band.
  frequency: FREQUENT
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "the presence of LVOTO, which occurs in about 20% of cases"
    explanation: Consensus-stated frequency supporting the FREQUENT band.
- category: Clinical
  name: Cardiac arrest
  description: >
    Occurs in a small but consequential minority, driven by ventricular arrhythmia on a
    prolonged-QT substrate or by refractory shock.
  phenotype_term:
    preferred_term: Cardiac arrest
    term:
      id: HP:0001695
      label: Cardiac arrest
    temporality: ACUTE
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:40365782
    reference_title: "High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cardiogenic shock occurred in 6.6%, atrial fibrillation in 20.7%, cardiac arrest in 3.4%, congestive heart failure in 35.9%, and stroke in 5.3%."
    explanation: Frequency from the national inpatient cohort.
- category: Clinical
  name: Stroke
  description: >
    Cerebral embolism, chiefly from apical mural thrombus, complicates about one admission
    in twenty.
  phenotype_term:
    preferred_term: Stroke
    term:
      id: HP:0001297
      label: Stroke
    temporality: ACUTE
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:40365782
    reference_title: "High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cardiogenic shock occurred in 6.6%, atrial fibrillation in 20.7%, cardiac arrest in 3.4%, congestive heart failure in 35.9%, and stroke in 5.3%."
    explanation: Frequency from the national inpatient cohort.
- category: Clinical
  name: Left ventricular thrombus
  description: >
    Thrombus in the akinetic apical cavity, the substrate for embolic stroke and a
    time-limited indication for anticoagulation.
  phenotype_term:
    preferred_term: Left ventricular thrombus
    term:
      id: HP:0040412
      label: Left ventricular thrombus
    temporality: TRANSIENT
  reports_on:
  - target: Left ventricular mural thrombus
    relationship: READOUT_OF
    description: >
      This phenotype is the clinical (echocardiographic) detection of the mural
      thrombus mechanism node.
    evidence:
    - reference: PMID:29850820
      reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Severe LV dysfunction with extended apical ballooning entails the risk of an LV thrombus and subsequent systemic embolism."
      explanation: Ties the thrombus explicitly to extended apical ballooning and states the embolic consequence.
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Severe LV dysfunction with extended apical ballooning entails the risk of an LV thrombus and subsequent systemic embolism."
    explanation: Ties the thrombus explicitly to extended apical ballooning and states the embolic consequence.
- category: Laboratory
  name: Elevated cardiac troponin
  description: >
    Troponin rises but only modestly, and the mismatch between a small troponin and a large
    territory of akinesis is one of the most useful discriminators from infarction at the
    bedside.
  phenotype_term:
    preferred_term: Increased circulating troponin concentration
    term:
      id: HP:0410173
      label: Increased circulating troponin I concentration
    temporality: ACUTE
  reports_on:
  - target: Contraction band necrosis and focal myocytolysis
    relationship: READOUT_OF
    description: >
      Troponin release reflects myocyte injury from the contraction-band necrosis
      lesion, though only modestly relative to the extent of dysfunction.
    evidence:
    - reference: PMID:15703419
      reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Endomyocardial biopsy showed mononuclear infiltrates and contraction-band necrosis."
      explanation: Human tissue confirmation of the injury the troponin readout tracks, from the same defining case series that also reports the modest troponin elevation.
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:15703419
    reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Seventeen patients had mildly elevated serum troponin I levels"
    explanation: Documents both the elevation and its modest magnitude in 17 of 19 patients.
- category: Laboratory
  name: Elevated brain natriuretic peptide
  description: >
    Natriuretic peptide rises steeply and out of proportion to the troponin. The ratio of
    the two is the single most discriminating biochemical feature against acute coronary
    syndrome and is incorporated into the InterTAK diagnostic score.
  phenotype_term:
    preferred_term: Increased circulating brain natriuretic peptide concentration
    term:
      id: HP:0033534
      label: Increased circulating brain natriuretic peptide concentration
    temporality: ACUTE
  reports_on:
  - target: Acute left ventricular systolic dysfunction
    relationship: READOUT_OF
    description: >
      Natriuretic peptide release reflects the wall stress produced by the acute
      systolic impairment, out of proportion to the concurrent troponin rise.
    evidence:
    - reference: PMID:29850820
      reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Takotsubo syndrome is frequently associated with a substantial increase in the plasma levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) reaching its peak approximately 24–48 h after symptom onset"
      explanation: States the substantial elevation this readout tracks and its time course.
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Takotsubo syndrome is frequently associated with a substantial increase in the plasma levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) reaching its peak approximately 24–48 h after symptom onset"
    explanation: States both the elevation and that it is a frequent feature, which is what the VERY_FREQUENT band rests on, and dates the peak to 24 to 48 hours.
- category: Behavioral
  name: Anxiety
  description: >
    Pre-existing anxiety and mood disorder are markedly over-represented, and psychological
    distress commonly follows the event as well as preceding it. In the registry the excess
    of neurologic and psychiatric disease over matched acute coronary syndrome controls is
    one of the largest single differences between the two populations.
  phenotype_term:
    preferred_term: Anxiety
    term:
      id: HP:0000739
      label: Anxiety
    temporality: CHRONIC
  evidence:
  - reference: PMID:26332547
    reference_title: "Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "rates of neurologic or psychiatric disorders were higher (55.8% vs. 25.7%)"
    explanation: Quantifies the excess psychiatric and neurologic burden relative to matched acute coronary syndrome patients.
progression:
- phase: Acute phase
  notes: >
    The first 24 to 72 hours, when the wall-motion abnormality is maximal and the risk of
    cardiogenic shock, outflow obstruction, and malignant arrhythmia is concentrated. This
    is also the window in which the diagnosis is usually made, by angiography excluding
    obstructive disease in a patient whose ventriculogram shows circumferential akinesis.
  evidence:
  - reference: PMID:26332547
    reference_title: "Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Rates of severe in-hospital complications including shock and death were similar in the two groups"
    explanation: Establishes that acute-phase risk matches that of acute coronary syndrome rather than being benign.
- phase: Recovery phase
  notes: >
    Over the following two to four weeks ejection fraction normalises in the great majority.
    Recovery is spontaneous; no therapy has been shown to accelerate it.
  evidence:
  - reference: PMID:15703419
    reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "rapidly resolved in all patients"
    explanation: Documents complete recovery of systolic function in every patient in the defining series.
- phase: Chronic subclinical phase
  notes: >
    After ejection fraction normalises, a substantial fraction of survivors retain abnormal
    strain and impaired myocardial energetics, remain symptomatic, and carry a long-term
    event rate approaching that of acute coronary syndrome survivors. Recurrence affects
    roughly four to ten percent, often in a different ballooning pattern.
  evidence:
  - reference: PMID:35344411
    reference_title: "Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "patients with takotsubo syndrome have persistent subtle ongoing cardiac dysfunction, and many continue to have limiting symptoms despite restoration of left ventricular ejection fraction"
    explanation: Defines the chronic subclinical phase and its symptomatic burden.
diagnosis:
- name: Coronary angiography and left ventriculography
  description: >
    Performed in essentially every case, because the presentation is indistinguishable from
    acute coronary syndrome and the diagnosis is partly one of exclusion. Ventriculography
    at the same sitting demonstrates the circumferential wall-motion abnormality and permits
    direct measurement of an outflow tract gradient on pigtail pullback.
  diagnosis_term:
    preferred_term: coronary angiography
    term:
      id: NCIT:C100085
      label: Coronary Angiography
  evidence:
  - reference: PMID:15703419
    reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All patients underwent coronary angiography and serial echocardiography"
    explanation: Angiography is the mandatory step that excludes the condition being mimicked.
- name: Transthoracic echocardiography
  description: >
    First-line and serial imaging: it identifies the regional wall-motion abnormality,
    detects and quantifies a dynamic outflow gradient and systolic anterior motion of the
    mitral valve, and documents recovery. Speckle-tracking strain may stay abnormal after
    ejection fraction has normalised.
  diagnosis_term:
    preferred_term: echocardiography
    term:
      id: NCIT:C16525
      label: Echocardiography Test
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a pressure gradient can be detected and quantified using Doppler echocardiography using continuous wave Doppler"
    explanation: Consensus statement of echocardiography's specific role in detecting the outflow obstruction that alters management.
- name: Electrocardiography
  description: >
    Shows diffuse ST elevation early, then deep diffuse T-wave inversion and QTc
    prolongation. The ECG cannot distinguish takotsubo from anterior infarction at
    presentation, which is precisely why angiography is mandatory, but serial tracings are
    informative and QTc guides arrhythmic risk and drug choice.
  diagnosis_term:
    preferred_term: electrocardiography
    term:
      id: NCIT:C38053
      label: Electrocardiography
  evidence:
  - reference: PMID:15703419
    reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Diffuse T-wave inversion and a prolonged QT interval occurred in most patients."
    explanation: The electrocardiographic findings the test is performed to detect.
- name: Cardiac magnetic resonance imaging
  description: >
    The decisive adjunct when the diagnosis is uncertain. Takotsubo shows regional oedema
    without the ischaemic late gadolinium enhancement pattern of infarction and without the
    subepicardial pattern of myocarditis. Imaging is most informative within the first week.
    Iron-oxide-enhanced protocols additionally reveal the macrophage infiltrate, though that
    remains a research technique.
  diagnosis_term:
    preferred_term: magnetic resonance imaging
    term:
      id: NCIT:C16809
      label: Magnetic Resonance Imaging
  evidence:
  - reference: PMID:30586731
    reference_title: "Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "patients with takotsubo cardiomyopathy underwent multiparametric cardiac magnetic resonance imaging, including ultrasmall superparamagnetic particles of iron oxide (USPIO) enhancement for detection of inflammatory macrophages in the myocardium"
    explanation: Documents the multiparametric cardiac magnetic resonance protocol and its tissue-characterisation capability.
- name: Cardiac troponin measurement
  description: >
    Troponin is measured to establish myocardial injury and, more usefully, to quantify how
    small it is relative to the extent of dysfunction. A troponin proportionate to a large
    akinetic territory argues for infarction instead.
  diagnosis_term:
    preferred_term: troponin measurement
    term:
      id: NCIT:C111327
      label: Troponin Measurement
  evidence:
  - reference: PMID:15703419
    reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Seventeen patients had mildly elevated serum troponin I levels, but only 1 of 19 had angiographic evidence of clinically significant coronary disease."
    explanation: Shows the troponin-to-coronary-anatomy mismatch that the measurement is used to detect.
- name: Natriuretic peptide measurement
  description: >
    B-type natriuretic peptide or its N-terminal prohormone is markedly elevated, out of
    proportion to the troponin, and the ratio between them is a core discriminator built
    into the InterTAK diagnostic score.
  diagnosis_term:
    preferred_term: brain natriuretic peptide measurement
    term:
      id: NCIT:C74735
      label: Brain Natriuretic Peptide Measurement
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Takotsubo syndrome is frequently associated with a substantial increase in the plasma levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) reaching its peak approximately 24–48 h after symptom onset"
    explanation: States the substantial elevation the measurement is performed to detect, and its time course.
treatments:
- name: Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy
  description: >
    The only pharmacologic class with registry evidence of a survival signal in this
    syndrome, and the one associated with lower recurrence. The evidence is observational
    and propensity-matched rather than randomised, so it supports a preference rather than a
    proven benefit, but the asymmetry against beta-blockade in the same dataset is the
    reason these agents are usually the first long-term choice.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: ACE inhibitor
      term:
        id: NCIT:C247
        label: ACE Inhibitor
  target_mechanisms:
  - target: Acute left ventricular systolic dysfunction
    treatment_effect: MODULATES
    description: >
      Afterload reduction and neurohormonal blockade support recovery of left ventricular
      function and are associated with improved survival.
    evidence:
    - reference: PMID:29850820
      reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The use of ACEi or ARB was associated with improved survival at 1-year follow-up even after propensity matching."
      explanation: The strongest available treatment-outcome association in the syndrome, reported by the consensus document from registry data.
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Beta-blocker therapy after hospital discharge does not appear to prevent recurrence,2,144 whereas ACEi or ARB are associated with a lower prevalence of recurrence."
    explanation: Directly contrasts the two long-term options on recurrence, which is the basis for preferring renin-angiotensin blockade.
- name: Beta-adrenergic blockade
  description: >
    Mechanistically the most attractive drug in the syndrome and the one that has repeatedly
    failed to show benefit. Blocking the receptor through which the catecholamine surge acts
    ought to work, and in animal models combined alpha- and beta-blockade does attenuate the
    ballooning. In patients, registry data show no survival benefit and no reduction in
    recurrence, and acute use is constrained by bradycardia, hypotension, low ejection
    fraction, and the torsade risk of a prolonged QT. Beta-blockade does have a specific
    acute role in relieving dynamic outflow obstruction. The gap between the mechanism and
    the outcome is curated as an open controversy.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: beta-adrenergic antagonist
      term:
        id: NCIT:C29576
        label: Beta-Adrenergic Antagonist
  target_mechanisms:
  - target: Dynamic left ventricular outflow tract obstruction
    treatment_effect: INHIBITS
    description: >
      Slowing and reducing basal hypercontractility widens the outflow tract and lowers the
      gradient.
    evidence:
    - reference: PMID:29850820
      reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "beta-blockers may improve LVOTO, but are contraindicated in acute and severe heart failure with low LVEF, hypotension, and in those with bradycardia"
      explanation: States both the specific indication and the constraints that limit it.
  - target: Sympathoadrenal activation and catecholamine surge
    treatment_effect: INHIBITS
    description: >
      Receptor-level blockade of the catecholamine signal, the mechanistic rationale that
      clinical outcome data have not borne out.
    evidence:
    - reference: PMID:15240400
      reference_title: "Emotional stress-induced Tako-tsubo cardiomyopathy: animal model and molecular mechanism."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: "Immobilization stress (IMO) of rats can reproduce these ECG and LVG changes, both of which are normalized by combined blockade of alpha- and beta-adrenoceptors."
      explanation: The animal evidence that adrenoceptor blockade prevents the syndrome, which is the rationale; note it required combined alpha and beta blockade, not beta alone.
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "In contrast, there was no evidence of any survival benefit for the use of beta-blockers.2 Moreover, one-third of patients experienced a TTS recurrence during beta-blockade2"
    explanation: Refutes the survival and recurrence-prevention rationale for beta-blockade despite its mechanistic appeal.
- name: Anticoagulation for left ventricular thrombus
  description: >
    Indicated for demonstrated apical thrombus, and considered for extensive apical akinesis
    with severely depressed function. The unusual feature is that the indication is
    self-limiting: as the apex recovers, the substrate disappears, so this is one of the few
    settings in which anticoagulation is started with a planned stop date.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: anticoagulant
      term:
        id: NCIT:C263
        label: Anticoagulant Agent
  target_mechanisms:
  - target: Left ventricular mural thrombus
    treatment_effect: INHIBITS
    description: >
      Anticoagulation prevents propagation and embolisation of apical thrombus while the
      akinetic segment recovers.
    evidence:
    - reference: PMID:40365782
      reference_title: "High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Cardiogenic shock occurred in 6.6%, atrial fibrillation in 20.7%, cardiac arrest in 3.4%, congestive heart failure in 35.9%, and stroke in 5.3%."
      explanation: Quantifies the embolic burden that anticoagulation targets; PARTIAL because the cohort study reports the complication rate and not the effect of anticoagulation on it.
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Although evidence is lacking, anticoagulation with intravenous/subcutaneous heparin would appear to be appropriate in such patients and post-discharge oral anticoagulation or antiplatelet therapy may be considered on an individual, per-patient basis."
    explanation: The consensus recommendation, stated with its own caveat that the evidence base for it is lacking, which is why this treatment is curated as rationally targeted rather than trial-proven.
- name: Diuretic therapy for pulmonary congestion
  description: >
    Standard management of the acute pulmonary oedema. Nitrates, which would otherwise be a
    natural companion, must be withheld if there is outflow tract obstruction, because
    reducing preload worsens the gradient.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  target_mechanisms:
  - target: Acute left ventricular systolic dysfunction
    treatment_effect: MODULATES
    description: >
      Decongestion relieves the pulmonary oedema produced by the acute fall in systolic
      function.
    evidence:
    - reference: PMID:29850820
      reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Diuretics are indicated in patients with pulmonary oedema."
      explanation: The consensus indication.
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "nitroglycerin is useful to reduce LV and RV filling pressures and afterload in the case of acute heart failure; however, the administration of nitroglycerin in the presence of LVOTO has been found to worsen the pressure gradient"
    explanation: Documents the conditional nature of vasodilator use alongside diuresis in this syndrome.
- name: Mechanical circulatory support for refractory shock
  description: >
    For shock that does not respond, or that cannot be treated with inotropes because of
    outflow obstruction, temporary mechanical support bridges the patient through the days
    to weeks until the myocardium recovers. Device choice is dictated by the same
    physiology: a device that unloads the left ventricle is preferable, whereas
    veno-arterial extracorporeal support without unloading raises afterload and can worsen
    an outflow gradient.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: percutaneous ventricular assist device placement
    term:
      id: NCIT:C172592
      label: Percutaneous Ventricular Assist Device Placement
  target_mechanisms:
  - target: Cardiogenic shock
    treatment_effect: BYPASSES
    description: >
      Temporary circulatory support maintains systemic perfusion until spontaneous recovery
      of ventricular function, which in this syndrome takes days rather than months.
    evidence:
    - reference: PMID:32473281
      reference_title: "Mechanical circulatory support for Takotsubo syndrome: a systematic review and meta-analysis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Temporary mechanical circulatory support (MCS) appears attractive as bridge-to-recovery, but prospective studies are lacking."
      explanation: States the bridge-to-recovery rationale that this edge represents, together with the absence of prospective evidence for it.
    - reference: PMID:32473281
      reference_title: "Mechanical circulatory support for Takotsubo syndrome: a systematic review and meta-analysis."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Median time on MCS was 3 (IQR: 2-7) days, with an overall survival of 94.6%."
      explanation: Quantifies both the short bridging interval the reversible physiology allows and the survival in supported patients, which is the outcome the bypass edge claims.
  evidence:
  - reference: PMID:32473281
    reference_title: "Mechanical circulatory support for Takotsubo syndrome: a systematic review and meta-analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The overall number of publications on MCS for TS increased over time, as did those using veno-arterial extracorporeal membrane oxygenation (V-A ECMO) and Impella, while those using intra-aortic balloon pump declined."
    explanation: Documents the shift in device selection toward ventricular unloading and away from the intra-aortic balloon pump, which is the device-choice claim in this treatment's description.
  - reference: PMID:32473281
    reference_title: "Mechanical circulatory support for Takotsubo syndrome: a systematic review and meta-analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Currently available clinical data support this approach. Prospective studies are needed to evaluate safety and efficacy of different devices as well as timing of MCS in this special patient population."
    explanation: The authors' own verdict, supportive but explicitly not prospective; PARTIAL because 93 pooled individual cases with no comparator cannot establish efficacy.
  - reference: PMID:32473281
    reference_title: "Mechanical circulatory support for Takotsubo syndrome: a systematic review and meta-analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "For several reasons catecholamines, and especially inotropes, should be avoided in TS."
    explanation: States the reason mechanical rather than pharmacologic support is reached for in this syndrome, from a source about mechanical support rather than about drugs.
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In TTS patients treated with catecholamine drugs a 20% mortality has been reported81; although this may represent a selection bias due to the initial presentation of the patients."
    explanation: The catecholamine mortality signal that motivates seeking a non-pharmacologic alternative; PARTIAL because it is about drug therapy rather than about mechanical support, and the consensus flags its own confounding.
- name: Avoidance of catecholamine inotropes
  description: >
    A treatment defined by what is withheld. Giving catecholamines to a patient whose disease
    is caused by a catecholamine surge is mechanistically perverse, and in those with outflow
    obstruction it is haemodynamically harmful as well. Reported mortality among patients
    treated with catecholamines is high, though confounded by their being the sickest.
    Recognising this is arguably the single highest-yield management decision in the syndrome.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_mechanisms:
  - target: Sympathoadrenal activation and catecholamine surge
    treatment_effect: INHIBITS
    description: >
      Withholding exogenous catecholamines avoids compounding the causal exposure.
    evidence:
    - reference: PMID:29850820
      reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "In TTS patients treated with catecholamine drugs a 20% mortality has been reported81"
      explanation: The outcome signal underlying the avoidance recommendation, reported with its own caveat about selection bias.
  evidence:
  - reference: PMID:22732314
    reference_title: "High levels of circulating epinephrine trigger apical cardiodepression in a beta2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "It is precipitated by extreme stress and can be triggered by intravenous catecholamine administration, particularly epinephrine."
    explanation: Establishes that exogenous catecholamine administration can itself cause the syndrome, which is the mechanistic basis for avoiding it as therapy.
- name: Cardiac rehabilitation
  description: >
    Structured exercise-based rehabilitation addresses the part of the illness that ejection
    fraction recovery does not: the persistent exercise intolerance, fatigue, and autonomic
    dysfunction of the chronic subclinical phase. It is one of the few interventions aimed
    at the enduring vulnerability rather than the acute event.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: cardiac rehabilitation
    term:
      id: NCIT:C101234
      label: Cardiac Rehabilitation
  target_mechanisms:
  - target: Persistent subclinical myocardial dysfunction
    treatment_effect: MODULATES
    description: >
      Exercise training targets the residual functional impairment and autonomic
      dysregulation that outlast recovery of ejection fraction.
    evidence:
    - reference: PMID:35344411
      reference_title: "Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "many continue to have limiting symptoms despite restoration of left ventricular ejection fraction"
      explanation: Establishes the residual symptomatic target of rehabilitation; PARTIAL because the review documents the unmet need rather than the efficacy of rehabilitation against it.
  evidence:
  - reference: PMID:35344411
    reference_title: "Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "there is a lack of evidence-based interventions to treat the acute episode, to avoid recurrences, and to prevent major adverse cardiovascular events"
    explanation: Places rehabilitation in a field with no proven disease-modifying therapy; PARTIAL because it characterises the evidence vacuum rather than supporting this intervention.
- name: Psychological therapy and stress management
  description: >
    Given the trigger structure and the high burden of comorbid anxiety and mood disorder,
    psychological intervention is a rational secondary-prevention strategy and is under
    active investigation. It is not supported by outcome trials, and is curated here as a
    rationally targeted rather than an evidence-proven treatment.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: psychotherapy
    term:
      id: NCIT:C15308
      label: Psychotherapy
  target_mechanisms:
  - target: Acute emotional or physical stressor
    treatment_effect: MODULATES
    description: >
      Reducing stress reactivity is intended to lower the probability that a future stressor
      precipitates a recurrence.
    evidence:
    - reference: PMID:26332547
      reference_title: "Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "rates of neurologic or psychiatric disorders were higher (55.8% vs. 25.7%)"
      explanation: Establishes the psychiatric comorbidity that the intervention targets; PARTIAL because the registry documents the association and not the effect of treating it.
  evidence:
  - reference: PMID:30831580
    reference_title: "Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Severe activation of the sympathetic nervous system with catecholamine release caused by a dysfunctional limbic system has been proposed as a potential mechanism."
    explanation: Supplies the brain-level rationale for a psychological intervention; INDIRECT because it is a proposed mechanism, not evidence for the therapy.
genetic:
- name: ADRB1
  gene_term:
    preferred_term: ADRB1
    term:
      id: hgnc:285
      label: ADRB1
  relationship_type: UNKNOWN
  variant_origin: GERMLINE
  notes: >
    Beta1-adrenergic receptor, examined in candidate-gene association studies as a plausible
    modifier of individual susceptibility to a catecholamine surge. Associations have not
    replicated. Curated here as an investigated candidate with an unresolved relationship to
    disease rather than as a susceptibility locus: no variant in this gene has reached
    replicated genome-wide significance for takotsubo susceptibility, and no clinical gene
    panel exists. Recorded to document what has been investigated, not to assert an
    association.
- name: ADRB2
  gene_term:
    preferred_term: ADRB2
    term:
      id: hgnc:286
      label: ADRB2
  relationship_type: UNKNOWN
  variant_origin: GERMLINE
  notes: >
    Beta2-adrenergic receptor, the receptor through which the leading molecular mechanism
    operates. That makes it the strongest a priori candidate gene in the syndrome, which is
    exactly why the absence of a replicated genetic association is informative rather than
    merely null. Candidate-gene studies have not produced a replicated association.
- name: GRK5
  gene_term:
    preferred_term: GRK5
    term:
      id: hgnc:4544
      label: GRK5
  relationship_type: UNKNOWN
  variant_origin: GERMLINE
  notes: >
    G-protein-coupled receptor kinase 5, which phosphorylates and desensitises adrenergic
    receptors and could in principle set the threshold at which the receptor switch occurs.
    Candidate-gene status only, motivated by the receptor-desensitisation step of the
    adrenergic mechanism. Investigated, not established.
biochemical:
- name: Plasma epinephrine
  notes: >
    Markedly elevated at presentation, and specifically higher than in patients with
    comparably severe myocardial infarction, which is what makes the elevation mechanistic
    rather than merely a marker of illness severity.
  presence: INCREASED
  readouts:
  - target: Sympathoadrenal activation and catecholamine surge
    relationship: READOUT_OF
    description: >
      Plasma epinephrine is a direct measurement of the sympathoadrenal catecholamine
      surge node.
    evidence:
    - reference: PMID:15703419
      reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Plasma catecholamine levels at presentation were markedly higher among patients with stress-induced cardiomyopathy than among those with Killip class III myocardial infarction"
      explanation: The comparison against a haemodynamically matched control condition.
  evidence:
  - reference: PMID:15703419
    reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Plasma catecholamine levels at presentation were markedly higher among patients with stress-induced cardiomyopathy than among those with Killip class III myocardial infarction"
    explanation: The comparison against a haemodynamically matched control condition.
- name: Plasma norepinephrine
  notes: >
    Elevated alongside epinephrine. Notably, norepinephrine alone does not reproduce the
    apical pattern in the rat model, which is part of the argument that the phenotype is
    determined by the epinephrine-preferring beta2 receptor rather than by total sympathetic
    tone.
  presence: INCREASED
  readouts:
  - target: Sympathoadrenal activation and catecholamine surge
    relationship: READOUT_OF
    description: >
      Plasma norepinephrine is a direct measurement of the sympathoadrenal
      catecholamine surge node, alongside epinephrine.
    evidence:
    - reference: PMID:15703419
      reference_title: "Neurohumoral features of myocardial stunning due to sudden emotional stress."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Plasma catecholamine levels at presentation were markedly higher among patients with stress-induced cardiomyopathy than among those with Killip class III myocardial infarction"
      explanation: The comparison against a haemodynamically matched control condition, reported for plasma catecholamines generally, which includes norepinephrine.
  evidence:
  - reference: PMID:22732314
    reference_title: "High levels of circulating epinephrine trigger apical cardiodepression in a beta2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "a high intravenous epinephrine, but not norepinephrine, bolus produces the characteristic reversible apical depression of myocardial contraction"
    explanation: Distinguishes the two catecholamines mechanistically, which is why they are curated separately.
- name: Interleukin-6
  notes: >
    Raised roughly threefold against matched controls in the acute phase, and still elevated
    at five months. The persistence is the point: it is the best current biochemical
    correlate of the chronic subclinical phase.
  presence: INCREASED
  readouts:
  - target: Myocardial macrophage inflammatory infiltrate
    relationship: READOUT_OF
    description: >
      Serum interleukin-6 is the circulating cytokine correlate of the myocardial and
      systemic macrophage-driven inflammatory response.
    evidence:
    - reference: PMID:30586731
      reference_title: "Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Serum interleukin-6 (23.1±4.5 pg/mL versus 6.5±5.8 pg/mL; P<0.001) and chemokine (C-X-C motif) ligand 1 (1903±168 pg/mL versus 1272±177 pg/mL; P=0.01) concentrations and classic CD14++CD16- monocytes (90±0.5% versus 87±0.9%; P=0.01) were also increased"
      explanation: Reports the interleukin-6 rise alongside the monocyte-subset shift in the same cohort as the macrophage infiltrate finding.
  evidence:
  - reference: PMID:30586731
    reference_title: "Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Serum interleukin-6 (23.1±4.5 pg/mL versus 6.5±5.8 pg/mL; P<0.001)"
    explanation: Quantifies the acute elevation against matched controls.
- name: Brain natriuretic peptide
  notes: >
    Elevated out of proportion to troponin. The disproportion, not the absolute value, is
    what carries diagnostic information.
  presence: INCREASED
  biomarker_term:
    preferred_term: brain natriuretic peptide
    term:
      id: NCIT:C88523
      label: Brain Natriuretic Peptide 32
  readouts:
  - target: Acute left ventricular systolic dysfunction
    relationship: READOUT_OF
    description: >
      Circulating brain natriuretic peptide reflects the ventricular wall stress
      produced by the acute systolic impairment, disproportionately to troponin.
    evidence:
    - reference: PMID:29850820
      reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Takotsubo syndrome is frequently associated with a substantial increase in the plasma levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) reaching its peak approximately 24–48 h after symptom onset"
      explanation: States the substantial rise in plasma B-type natriuretic peptide that this marker records.
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Takotsubo syndrome is frequently associated with a substantial increase in the plasma levels of B-type natriuretic peptide (BNP) and N-terminal prohormone of brain natriuretic peptide (NT-proBNP) reaching its peak approximately 24–48 h after symptom onset"
    explanation: States the substantial rise in plasma B-type natriuretic peptide that this marker records.
prevalence:
- population: Hospitalised adults, United States
  measure_type: POINT_PREVALENCE
  prevalence_class: RARE
  notes: >
    199 890 admissions carrying a takotsubo diagnosis were identified in the Nationwide
    Inpatient Sample over 2016 to 2020, with a strong female predominance. The syndrome
    accounts for roughly one to three percent of presentations that initially look like
    acute coronary syndrome.
  evidence:
  - reference: PMID:40365782
    reference_title: "High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A total of 199 890 patients with Takotsubo were found in our database with 83% being female and higher prevalence with age, White race, and highest income."
    explanation: National inpatient denominator and the demographic distribution.
- population: International Takotsubo Registry
  measure_type: CASES_IN_LITERATURE
  prevalence_class: RARE
  notes: >
    Nearly 90 percent of registry patients are women, with a mean age in the late sixties,
    the demographic signature that any mechanistic account has to explain.
  evidence:
  - reference: PMID:26332547
    reference_title: "Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of 1750 patients with takotsubo cardiomyopathy, 89.8% were women (mean age, 66.8 years)."
    explanation: The registry demographic that defines the at-risk population.
differential_diagnoses:
- name: Acute myocardial infarction
  description: >
    The condition takotsubo mimics and the reason angiography is mandatory. Distinguishing
    features are a wall-motion abnormality that crosses coronary territories, unobstructed
    epicardial arteries, a troponin too small for the territory involved, a natriuretic
    peptide too large for the troponin, and complete recovery of function.
  evidence:
  - reference: PMID:33602474
    reference_title: "Pathophysiology of Takotsubo Syndrome: JACC State-of-the-Art Review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "TTS is now routinely diagnosed in patients who present with acute chest pain, electrocardiographic changes, troponin elevation, unobstructed coronary arteries, and a typical pattern of circumferential left ventricular wall motion abnormalities"
    explanation: States the discriminating combination of unobstructed arteries with a circumferential abnormality.
- name: Acute myocarditis
  description: >
    Also presents with chest pain, troponin release, and unobstructed coronaries. Cardiac
    magnetic resonance separates them: myocarditis shows subepicardial or midmyocardial late
    gadolinium enhancement, whereas takotsubo shows oedema without that ischaemic or
    inflammatory scar pattern.
  evidence:
  - reference: PMID:30586731
    reference_title: "Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "patients with takotsubo cardiomyopathy underwent multiparametric cardiac magnetic resonance imaging"
    explanation: Establishes multiparametric cardiac magnetic resonance as the tissue-characterisation tool used to separate the two; PARTIAL because the study is not a diagnostic-accuracy comparison against myocarditis.
- name: Pheochromocytoma crisis
  description: >
    Produces an essentially identical catecholamine cardiomyopathy, with the same
    contraction-band histology, from an endogenous tumour source rather than a stress
    response. It matters because it is treatable and recurrent if missed, and because it is
    strong independent evidence that the catecholamine mechanism is causal.
  evidence:
  - reference: PMID:22732314
    reference_title: "High levels of circulating epinephrine trigger apical cardiodepression in a beta2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "It is precipitated by extreme stress and can be triggered by intravenous catecholamine administration, particularly epinephrine."
    explanation: Establishes that a pure catecholamine exposure reproduces the syndrome, which is the shared mechanism with pheochromocytoma; PARTIAL because the source addresses exogenous rather than tumour-derived catecholamine.
clinical_burden:
  burden_level: HIGH
  rationale: >
    In-hospital mortality is around 6.5 percent and is not falling, which is comparable to
    acute myocardial infarction and refutes the historical description of the syndrome as
    benign. More than a third of admitted patients develop congestive heart failure, one in
    five atrial fibrillation, and one in fifteen cardiogenic shock. Men are a small minority
    of cases but die at more than twice the rate of women, for reasons that are unexplained.
  notes: >
    The burden is not confined to the admission. Survivors commonly remain fatigued,
    breathless, and exercise-limited after ejection fraction has normalised, and their
    long-term major adverse cardiovascular event rate approaches that of acute coronary
    syndrome survivors. Recurrence affects roughly four to ten percent. No therapy has been
    shown in a randomised trial to alter any of this.
  evidence:
  - reference: PMID:40365782
    reference_title: "High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Mortality was high at 6.5% with no significant improvement over the years studied."
    explanation: National inpatient mortality with an explicit statement that it is not falling.
  - reference: PMID:40365782
    reference_title: "High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy With More Than Double Mortality in Men Without Improvement in Outcome Over the Years."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Mortality was more than double in men in comparison to women (11.2% versus 5.5%)."
    explanation: Quantifies the unexplained sex disparity in a national cohort.
  - reference: PMID:35344411
    reference_title: "Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "many continue to have limiting symptoms despite restoration of left ventricular ejection fraction"
    explanation: Documents the residual symptomatic burden that the recovered ejection fraction conceals.
discussions:
- discussion_id: beta_blockade_mechanism_outcome_gap
  prompt: >
    Why does beta-adrenergic blockade, which targets the mechanism that causes takotsubo
    syndrome, fail to improve survival or prevent recurrence?
  kind: CONTROVERSY
  status: OPEN
  attaches_to:
  - pathophysiology#Sympathoadrenal activation and catecholamine surge
  - pathophysiology#Beta2-adrenergic receptor switch from Gs to Gi coupling
  - pathophysiology#Coronary microvascular dysfunction
  rationale: >
    Every element of the accepted mechanism predicts that beta-blockade should work: the
    trigger is a catecholamine surge, the molecular lesion is a beta2-adrenergic receptor
    switch, and in animals combined adrenoceptor blockade abolishes the ballooning. Registry
    data nonetheless show no survival benefit, and a third of patients recur while taking a
    beta-blocker. Several explanations are live and mutually compatible. Alpha-adrenergic
    receptors dominate the coronary microcirculation and are untouched by beta-blockade,
    which would matter if the microvascular arm carries more causal weight than assumed. The
    animal evidence required combined alpha and beta blockade, not beta alone, so the
    preclinical result may never have supported beta-monotherapy. Blockade started after
    presentation cannot prevent a surge that has already happened, so an acute-phase trial
    may be testing the wrong window. And if the receptor switch is partly cardioprotective
    rather than purely injurious, blocking it could offset its own benefit. Distinguishing
    these matters because they imply different drugs and different timing.
  proposed_experiments:
  - experiment_id: exp_tts_combined_alpha_beta_blockade_trial
    name: Randomised trial of combined alpha- and beta-adrenoceptor blockade versus beta-blockade alone for recurrence prevention
    description: >-
      Randomise takotsubo survivors at hospital discharge to a combined alpha- and
      beta-blocking agent, a selective beta-blocker, or renin-angiotensin blockade alone,
      and follow recurrence, major adverse cardiovascular events, and global longitudinal
      strain for three years.
    decision_criterion: >-
      A reduction in recurrence with combined blockade but not with beta-blockade alone
      would support the alpha-receptor and microvascular explanation and would reconcile the
      animal and clinical evidence; equivalence across all three arms would argue that
      adrenergic blockade after the index event is simply too late.
  evidence:
  - reference: PMID:29850820
    reference_title: "International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In contrast, there was no evidence of any survival benefit for the use of beta-blockers.2 Moreover, one-third of patients experienced a TTS recurrence during beta-blockade2 suggesting that other receptors such as alpha-receptors, that are more prevalent in the coronary microcirculation, might be involved."
    explanation: States both the negative outcome and the consensus document's own proposed explanation for it.
- discussion_id: brain_heart_axis_causal_direction
  prompt: >
    Is the limbic and autonomic network hypoconnectivity seen in takotsubo patients a
    pre-existing vulnerability that permits the syndrome, or a consequence of having had it?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Central limbic and autonomic network hypoconnectivity
  rationale: >
    The imaging is unambiguous that connectivity in sympathetic- and
    parasympathetic-associated subnetworks is reduced, involving exactly the regions that
    generate autonomic outflow. The direction of causation is not established, because every
    published cohort was scanned after the cardiac event. The distinction is not academic: a
    pre-existing central lesion would make takotsubo a disorder of autonomic regulation that
    happens to present cardiologically, would explain why some patients recur and others
    never do, and would make central rather than cardiac intervention the rational target.
    A reactive change would instead make the brain findings a marker of illness severity.
  proposed_experiments:
  - experiment_id: exp_tts_prospective_neuroimaging_cohort
    name: Prospective neuroimaging in a population at elevated takotsubo risk
    description: >-
      Acquire resting-state functional magnetic resonance imaging in a large cohort scanned
      for unrelated indications or as part of a population imaging study, then ascertain
      incident takotsubo syndrome over subsequent years and compare baseline limbic and
      autonomic connectivity in those who develop the syndrome against matched controls who
      do not.
    decision_criterion: >-
      Reduced baseline connectivity preceding the event would establish it as a predisposing
      lesion; connectivity indistinguishable from controls before the event, with the
      abnormality appearing only afterwards, would establish it as reactive.
  evidence:
  - reference: PMID:30831580
    reference_title: "Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We found parasympathetic- and sympathetic-associated subnetworks both showing reduced resting state functional connectivity in TTS patients compared with controls."
    explanation: The observation whose temporal direction is the open question; the study design is cross-sectional and post-event.
- discussion_id: animal_models_and_the_sex_bias
  prompt: >
    Do rodent immobilisation and catecholamine-infusion models reproduce the biology
    responsible for the overwhelming postmenopausal female predominance of takotsubo
    syndrome in humans?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Beta2-adrenergic receptor switch from Gs to Gi coupling
  - pathophysiology#Central limbic and autonomic network hypoconnectivity
  rationale: >
    The animal models are genuinely strong on the core mechanism: immobilisation stress and
    epinephrine boluses reproduce the ST changes, the apical ballooning, and the reversibility,
    and pharmacologic blockade abolishes them. What they reproduce far less well is the single
    most striking epidemiologic fact about the human syndrome, that roughly nine in ten
    patients are postmenopausal women. Rat work shows that raising serum estrogen partially
    attenuates the cardiac changes, which is a real signal in the right direction but a much
    weaker effect than a nine-to-one sex ratio implies, and the models do not address the
    human limbic and insular findings at all. Two readings follow. Either the sex bias arises
    from a mechanism the models do not capture, in which case negative model results for
    hormone-directed interventions are uninformative about patients; or estrogen modulation of
    beta-adrenergic coupling is the right mechanism and the models simply underpower it. This
    matters directly for whether hormone-related susceptibility is worth pursuing
    therapeutically.
  proposed_experiments:
  - experiment_id: exp_tts_ovariectomised_aged_model
    name: Aged ovariectomised rodent model with graded estrogen replacement
    description: >-
      Compare takotsubo induction rate and severity across intact young, intact aged,
      ovariectomised aged, and ovariectomised aged animals receiving graded estrogen
      replacement, using a standardised epinephrine bolus, with beta2-adrenergic receptor
      density and Gs-to-Gi coupling measured in apical and basal cardiomyocytes from each
      group.
    decision_criterion: >-
      A susceptibility gradient tracking estrogen exposure, with a matching shift in apical
      beta2-adrenergic receptor coupling, would establish the hormonal mechanism as
      sufficient to explain the human sex bias; a comparable induction rate across hormone
      states would show the models lack the relevant biology and would redirect attention to
      the central autonomic arm.
  evidence:
  - reference: PMID:15240400
    reference_title: "Emotional stress-induced Tako-tsubo cardiomyopathy: animal model and molecular mechanism."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "An increase of serum estrogen partially attenuated these cardiac changes."
    explanation: The estrogen signal in the rat model is real but explicitly partial, which is the mismatch against a nine-to-one human sex ratio.
  - reference: PMID:26332547
    reference_title: "Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Of 1750 patients with takotsubo cardiomyopathy, 89.8% were women (mean age, 66.8 years)."
    explanation: The human sex and age distribution that the models are being asked to reproduce.
- discussion_id: polygenic_susceptibility_absent_locus
  prompt: >
    Is there a genuine heritable component to takotsubo susceptibility, and if so why has no
    locus replicated despite two decades of candidate-gene work?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - pathophysiology#Beta2-adrenergic receptor switch from Gs to Gi coupling
  rationale: >
    Familial clustering has been reported repeatedly, and the adrenergic pathway supplies
    unusually well-motivated candidate genes, ADRB2 above all, since it encodes the receptor
    through which the leading mechanism operates. Yet no variant has been conclusively
    associated, and the field has moved to a polygenic and gene-environment framing largely
    by elimination. Three explanations remain open. The effect may be genuinely polygenic
    with per-variant effects far below what candidate-gene sample sizes can detect. The
    heritable component may not be cardiac at all but reside in central stress-response and
    autonomic regulation, in which case adrenergic candidate genes were the wrong place to
    look. Or the familial reports may reflect shared environment and ascertainment rather
    than genetics. Resolving this determines whether a susceptibility panel is a realistic
    goal or a category error.
  proposed_experiments:
  - experiment_id: exp_tts_gwas_consortium
    name: Adequately powered multinational genome-wide association study of takotsubo syndrome
    description: >-
      Pool takotsubo cases across the international registries with matched controls to reach
      a sample size capable of detecting common variants of modest effect, test for enrichment
      in adrenergic, stress-response, and neuropsychiatric pathways, and evaluate whether a
      polygenic score derived in one cohort predicts case status in an independent one.
    decision_criterion: >-
      Replicated genome-wide significant loci, or a polygenic score that transfers between
      cohorts, would establish a heritable component and localise it; a well-powered null
      would make a shared-environment explanation the leading account of familial clustering.
  evidence:
  - reference: PMID:40723798
    reference_title: "The Genetic Puzzle of the Stress-Induced Cardiomyopathy (Takotsubo Syndrome): State of Art and Future Perspectives."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Despite a large number of investigations, no definitive genetic markers associated with TS risk have been conclusively identified. The lack of a clear Mendelian inheritance pattern suggests a multifactorial etiology and pathogenesis, likely involving complex gene-environment interactions and a polygenic background."
    explanation: States the negative result and the polygenic reframing that the proposed study would test directly.
notes: >
  No GeneReviews chapter exists for takotsubo cardiomyopathy, and none would be expected:
  the syndrome has no established causal gene, no Mendelian inheritance pattern, and no
  clinical genetic test. The three genes recorded in the genetic section are all curated with
  relationship_type UNKNOWN. They are there to document what has been investigated and found
  wanting, which is itself informative given that ADRB2 encodes the receptor central to the
  accepted mechanism.

  Two ontology notes. First, several phenotypes here have no takotsubo-specific HPO term and
  are bound to the closest general cardiac term, with the specific meaning carried in
  preferred_term and description. Second, the troponin phenotype is bound to
  HP:0410173 (Increased circulating troponin I concentration), matching the assay the cited
  evidence actually used. HPO has no assay-agnostic troponin term, so where an assay-specific
  term must be chosen the right one is the one the evidence reports; preferred_term carries the
  general clinical claim.

  Deep-research provenance: this entry was curated from a claude_code deep-research report
  (research/Takotsubo_Cardiomyopathy-deep-research-claude_code.md) treated as leads only. The
  NEC preflight returned SKIP because MONDO records no causal gene for MONDO:0019018; manual
  synonym and identifier checks against the MONDO record confirmed the correct entity. Four
  ontology identifiers suggested by the provider were verified against OAK and found to point
  at unrelated concepts (HP:0001681 is Angina pectoris, not a ventricular morphology term;
  HP:0033539 is Bilateral apical pulmonary fibrosis, not ST-segment elevation; CL:0002350 is
  endocardial cell, not cardiac microvascular endothelial cell; CHEBI:33569 is noradrenaline,
  not epinephrine), and one suggested PMID for the beta2-adrenergic receptor switch paper was
  a neuroscience article on Eph and ephrin signalling. All were corrected before curation.

📚

References & Deep Research

Deep Research

1

Claude Code ▸

Takotsubo Cardiomyopathy — Comprehensive Research Report

claude-haiku-4-5-20251001, claude-sonnet-5 48 citations 2026-08-09T21:45:35.269471

Takotsubo Cardiomyopathy — Comprehensive Research Report

1. Disease Information

Overview. Takotsubo cardiomyopathy (Takotsubo syndrome, TTS; also "stress cardiomyopathy," "apical ballooning syndrome," "broken heart syndrome") is an acute, reversible form of left ventricular (LV) systolic and diastolic dysfunction characterized by regional wall-motion abnormalities that extend beyond a single epicardial coronary artery territory, occurring in the absence of obstructive coronary artery disease sufficient to explain the degree of dysfunction. It classically follows an acute emotional or physical stressor and produces a clinical picture that mimics acute myocardial infarction (chest pain, ST-segment changes, troponin elevation) but with disproportionately elevated natriuretic peptides relative to troponin, and near-complete recovery of LV function within days to weeks in most patients. The name derives from the Japanese fishing pot ("tako-tsubo," octopus trap), which the classic apical-ballooned left ventricle resembles on ventriculography (Ravindran et al., 2024, Intern Med J, https://onlinelibrary.wiley.com/doi/10.1111/imj.16493).

Key identifiers: - MONDO: MONDO:0019018 - Orphanet: ORPHA:66529 ("Tako-Tsubo cardiomyopathy"; https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Expert=66529&lng=EN) - OMIM: No OMIM phenotype/gene entry exists — TTS is not classified as a monogenic Mendelian disorder - ICD-10-CM: I51.81 (Takotsubo syndrome) — the clinically used code (https://www.icd10data.com/ICD10CM/Codes/I00-I99/I30-I5A/I51-/I51.81); Orphanet cross-references ICD-10 I42.8 (Other cardiomyopathies) - ICD-11: BC43.5 - MeSH: D054549 (Takotsubo Cardiomyopathy)

Synonyms/alternative names: Takotsubo syndrome, apical ballooning syndrome, stress cardiomyopathy, stress-induced cardiomyopathy, broken heart syndrome, transient LV apical ballooning syndrome, ampulla cardiomyopathy, catecholamine cardiomyopathy, neurogenic stunned myocardium (overlapping construct).

Evidence basis: Knowledge of TTS derives overwhelmingly from aggregated disease-level resources — large multicenter registries (International Takotsubo [InterTAK] Registry, ~1,750+ patients; German-Italian Stress Cardiomyopathy [GEIST] Registry; Spanish RETAKO Registry), national hospital discharge/administrative databases (e.g., U.S. National Inpatient Sample), and systematic reviews/meta-analyses, supplemented by case reports/series and mechanistic studies in humans and animal models — rather than from individual-patient EHR mining, since there is no dedicated large-scale genomic biobank for this condition.

2. Etiology

Disease causal factors

TTS is best conceptualized as a stress-triggered, catecholamine-mediated, reversible cardiomyopathy rather than a disease with a single discrete cause. The unifying causal chain is: an acute emotional or physical/medical stressor → massive sympathoadrenal (catecholamine) surge and/or direct sympathetic nerve terminal norepinephrine release in myocardium → catecholamine-induced myocardial toxicity, coronary microvascular dysfunction, and altered β-adrenergic signal trafficking → reversible regional myocardial stunning ("takotsubo" pattern) (Y-Hassan & Tornvall, 2018, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603071/; Ghadri et al., Circulation 2022, https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.055854).

Risk factors

Genetic risk factors (susceptibility, not causal in the Mendelian sense): - No single causal gene has been identified. Candidate-gene association studies have examined variants in ADRB1 (β1-adrenergic receptor), ADRB2 (β2-adrenergic receptor), ADRA2C (α2C-adrenergic receptor), GRK5 (G-protein-coupled receptor kinase 5), BAG3 (Bcl-2-associated athanogene 3), and estrogen receptor genes, with conflicting/non-replicated results (https://pubmed.ncbi.nlm.nih.gov/19167638/; https://pubmed.ncbi.nlm.nih.gov/19944334/; https://pubmed.ncbi.nlm.nih.gov/25132214/). - A 2018 case-control study found "lack of genetic susceptibility" for candidate adrenergic-pathway variants tested individually (https://bmcmedgenet.biomedcentral.com/articles/10.1186/s12881-018-0544-6, PMC5842616). - A recent comprehensive review (2025) concludes: "these data support genetic heterogeneity in takotsubo cardiomyopathy susceptibility and a likely polygenic basis, conferring a cumulative effect on adrenergic pathway dysregulation" (https://pmc.ncbi.nlm.nih.gov/articles/PMC12292538/, PMID:40723798). Emerging GWAS efforts (Swedish discovery cohorts) implicate loci beyond adrenergic genes — including genes linked to psychiatric disease, lipid metabolism, and cardiac structural integrity — but sample sizes remain small and no locus reaches definitive genome-wide significance replication. - Rare familial clusters have been reported, suggesting a genetic contribution in a subset, but there is no defined Mendelian inheritance pattern; the mechanism is regarded as multifactorial/polygenic gene–environment interaction (https://pubmed.ncbi.nlm.nih.gov/27638020/; https://pmc.ncbi.nlm.nih.gov/articles/PMC8471495/).

Environmental/demographic risk factors: - Female sex and postmenopausal status — the dominant risk factor. Women >50 years account for 80–90% of cases (InterTAK Registry: 89.8% postmenopausal women, mean age 66.8 years) (https://pmc.ncbi.nlm.nih.gov/articles/PMC9999670/). - Acute emotional stress (grief, fear, anger, interpersonal conflict, financial distress) and acute physical stress/medical illness (surgery, sepsis, exacerbation of asthma/COPD, seizures, subarachnoid/intracerebral hemorrhage, trauma) are the two principal trigger categories; physical triggers are increasingly recognized as more common than emotional triggers in contemporary hospitalized cohorts (52.6% physical vs. 21% emotional in one series) (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714036/). - Pheochromocytoma/paraganglioma — a recognized secondary catecholamine-excess trigger (https://pubmed.ncbi.nlm.nih.gov/21474192/; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717601/); in a comparative series only 28.9% of pheochromocytoma-triggered TTS cases had an additional identifiable antecedent stressor, versus 65.7% of TTS overall. - Malignancy — increased TTS incidence in oncology patients (~53/100,000 chemotherapy-related hospitalizations vs. ~20.4/100,000 in the general population), and TTS prevalence among cancer patients (4–29% depending on cohort) exceeds background rates (https://pmc.ncbi.nlm.nih.gov/articles/PMC9666486/; https://pmc.ncbi.nlm.nih.gov/articles/PMC10800806/). - Psychiatric comorbidity: pre-existing anxiety and mood disorders, neuroticism, and Type D personality traits are overrepresented; pooled OR for psychological morbidity/stress exposure ~6.50 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888627/; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838620/). - Neurological disease (stroke, subarachnoid hemorrhage, seizure disorders, migraine) — reflects the brain-heart axis pathway. - COVID-19 and other acute infections/sepsis have been reported as physical triggers.

Protective factors

Estrogen/premenopausal status is the principal recognized protective factor, acting through modulation of cardiomyocyte β2-adrenergic receptor Gs/Gi coupling balance (see Mechanism, below) (https://pmc.ncbi.nlm.nih.gov/articles/PMC8977075/). No specific protective genetic variants or dietary/lifestyle protective factors are established in the literature.

Gene-environment interactions

The dominant conceptual model is that an acute catecholamine surge (environmental trigger) acts on a myocardium whose vulnerability is modulated by estrogen status (hormonal/environmental) and a polygenic background affecting adrenergic receptor density/coupling and stress-response pathways — i.e., genetic susceptibility lowers the threshold at which a given catecholamine surge produces cardiac injury, rather than genetics being causal on its own (https://pmc.ncbi.nlm.nih.gov/articles/PMC12292538/).

3. Phenotypes

TTS phenotypes span symptoms, clinical signs, laboratory abnormalities, and imaging-defined structural/functional abnormalities. Suggested HPO terms are given where a reasonable match exists (the HPO does not have a takotsubo-specific term; general cardiac phenotype terms apply).

Phenotype	Type	Suggested HPO term	Frequency	Notes
Acute chest pain	Symptom	HP:0100749 (Chest pain)	Most common (~75–90%) presenting symptom	Mimics ACS (https://www.ncbi.nlm.nih.gov/books/NBK538160/)
Dyspnea	Symptom	HP:0002094 (Dyspnea)	Common (~20%)	May be sole presenting symptom, esp. secondary TTS
Syncope	Symptom	HP:0001279 (Syncope)	~5–10%	Associated with arrhythmia/LVOTO
ST-segment elevation	Lab/ECG abnormality	HP:0033539 (ST segment elevation, if present in HPO) / free text	Common at presentation	Diffuse, not localized to one coronary territory
T-wave inversion	Lab/ECG abnormality	—	Common, often develops over 24–48h	Deep, diffuse
QT interval prolongation	Lab/ECG abnormality	HP:0001657 (Long QT interval)	Common	Predisposes to torsades de pointes
Elevated cardiac troponin	Laboratory abnormality	HP:0410174 (Elevated troponin I, if available) / free text	Universal, but modest	Disproportionately low relative to wall-motion abnormality extent
Elevated natriuretic peptide (BNP/NT-proBNP)	Laboratory abnormality	free text	Universal, disproportionately high	Key discriminator vs. MI
Regional wall motion abnormality (apical ballooning)	Clinical sign/imaging	HP:0001681 (Abnormal cardiac ventricle morphology) / free text	~80% classic apical pattern	InterTAK Registry data
Reduced left ventricular ejection fraction	Clinical sign	HP:0012664 (Abnormal left ventricular function)	Transient, mean nadir LVEF ~30–40%	Recovers over days–weeks
Left ventricular outflow tract obstruction	Clinical sign	free text	~15–25% (up to 18% in largest series)	Dynamic, worsened by inotropes
Cardiogenic shock	Clinical sign/complication	HP:0410174 / free text	~6.6–11.4%	Higher in physical-trigger/secondary TTS
Atrial fibrillation	Clinical sign/complication	HP:0005110 (Atrial fibrillation)	~20.7%	Most common arrhythmic complication after CHF
Congestive heart failure	Clinical sign/complication	HP:0001635 (Congestive heart failure)	~35.9% (most common complication)
Cardiac arrest	Complication	HP:0001695 (Sudden cardiac death, related)	~3.4%
Stroke	Complication	HP:0001297 (Stroke)	~5.3%	Embolic from LV thrombus or comorbid
Left ventricular thrombus	Clinical sign/complication	free text	~2–8%	Requires anticoagulation
Mitral regurgitation	Clinical sign	HP:0001653 (Mitral regurgitation)	Variable, often with SAM
Anxiety/mood disturbance	Behavioral	HP:0000739 (Anxiety) / HP:0000716 (Depression)	Elevated lifetime prevalence	Precedes and follows event

Characteristics: - Age of onset: Predominantly adult-onset, typically postmenopausal (mean age ~66–68 years); rare pediatric and premenopausal cases exist, usually with an identifiable severe physical trigger. - Severity: Variable — from mild transient dysfunction to fulminant cardiogenic shock; graded partly by ballooning pattern (global pattern carries the worst prognosis). - Progression: Acute onset, typically fully reversible over days to weeks (LVEF normalization usually within 1–4 weeks), though speckle-tracking strain studies show persistent subclinical dysfunction in a substantial minority even after LVEF normalizes (PMC12786540). - Frequency among affected individuals: Chest pain and dyspnea are the dominant presenting complaints (>90% combined); cardiogenic shock, arrhythmia, and thrombus are complications occurring in a minority (single-digit to ~35% depending on complication type, per National Inpatient Sample data, https://www.ahajournals.org/doi/10.1161/JAHA.124.037219).

Quality of life impact: Despite hemodynamic recovery, patients report persistent fatigue, reduced exercise tolerance, dyspnea, and emotional distress; post-discharge psychological morbidity includes posttraumatic stress symptoms, sexual distress, and reduced QoL, with anxiety (but not necessarily depression) preceding the event and psychological distress following it (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838620/).

4. Genetic/Molecular Information

Causal genes: None established as monogenic-causal; TTS is not an OMIM-listed Mendelian condition.
Pathogenic variants: No ACMG/AMP-classified pathogenic variants exist for TTS. Candidate-gene studies (ADRB1, ADRB2, ADRA2C, GRK5, BAG3) report inconsistent, non-replicated associations — classified in the field as research-stage susceptibility signals, not clinically actionable variants (https://pmc.ncbi.nlm.nih.gov/articles/PMC8471495/).
Variant type/class: Studies to date are predominantly SNP association studies (missense and regulatory-region polymorphisms in adrenergic pathway genes), not structural or splice-site variants.
Allele frequency: Not systematically characterized in population databases (gnomAD etc.) specific to TTS risk, since no variant has reached consensus significance.
Somatic vs. germline: All studied variants are germline; no somatic mutational component described.
Functional consequences: Proposed functional models involve altered adrenergic receptor density/desensitization kinetics (e.g., GRK5 variants altering β-adrenergic receptor phosphorylation/desensitization) that could plausibly modulate individual susceptibility to catecholamine-induced myocardial injury, but causality is unproven.
Modifier genes: Estrogen receptor gene variants have been proposed as modifiers interacting with menopausal status, but data are limited.
Epigenetic information: A systematic review (2021) on genetic and epigenetic factors in TTS notes an emerging but still preliminary literature on microRNA dysregulation and other epigenetic marks as candidate biomarkers/modifiers, without a validated causal epigenetic mechanism (https://pmc.ncbi.nlm.nih.gov/articles/PMC8471495/).
Chromosomal abnormalities: None reported as disease-associated.

GO/molecular pathway suggestions: GO:0071875 (adrenergic receptor signaling pathway), GO:0071870 (cellular response to catecholamine stimulus), GO:0007188 (adenylate cyclase-modulating G protein-coupled receptor signaling pathway), GO:0006874 (cellular calcium ion homeostasis).

5. Environmental Information

Environmental/toxin factors: Direct exogenous catecholamine or catecholamine-like drug exposure (e.g., iatrogenic epinephrine/adrenaline administration, dobutamine stress testing, illicit stimulant use, cocaine) is a recognized precipitant (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892140/ — iatrogenic adrenaline-induced mid-ventricular TTS).
Lifestyle/behavioral factors: Chronic psychosocial stress, acute severe emotional events (bereavement, "broken heart" scenarios), and acute anxiety states are behavioral/psychological precipitants rather than classical lifestyle exposures (smoking, diet) — no strong literature links smoking/diet/alcohol directly to TTS risk beyond general cardiovascular risk factor overlap.
Infectious agents: Not a primary etiology, but acute infection/sepsis and COVID-19 are recognized physical-stress triggers that can precipitate TTS as a secondary/physical-trigger phenotype, rather than TTS being an infectious disease per se.
Suggested ECTO/ontology framing: the acute physical/emotional stressor functions analogously to an "exposure" that TRIGGERS the pathophysiology (relevant environmental_effect: TRIGGERS framing per dismech conventions), with pheochromocytoma-derived endogenous catecholamine excess as a special internal/endocrine trigger.

6. Mechanism / Pathophysiology

TTS pathophysiology is now understood as multifactorial, converging on catecholamine-driven myocardial injury, coronary microvascular dysfunction, and disordered brain–heart signaling (Ghadri et al. 2022, Circulation, https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.055854; PMC12786540, 2025 review).

Causal chain (upstream → downstream)

Trigger (upstream): Acute emotional or physical stress → activation of hypothalamic-pituitary-adrenal axis and sympathetic nervous system.
Catecholamine surge: Massive systemic release of epinephrine, norepinephrine, and dopamine (2–3-fold or greater elevation vs. controls, and higher than levels seen in acute MI) from the adrenal medulla and sympathetic nerve terminals.
β-adrenergic receptor signal trafficking switch (molecular): At supraphysiologic epinephrine concentrations, the β2-adrenergic receptor undergoes a conformational/functional switch from Gs-protein to Gi-protein coupling (particularly pronounced in the LV apex, where β-receptor density is highest), converting what is normally a positive inotropic signal into a negative inotropic effect — the leading molecular explanation for the apex-predominant "ballooning" pattern (Nature Reviews Cardiology, https://www.nature.com/articles/ncpcardio1066; PMC6109068).
Direct catecholamine cardiotoxicity (cellular): Sustained β-adrenergic overstimulation → intracellular calcium overload → generation of reactive oxygen species, mitochondrial dysfunction, and impaired myocardial energetics (reduced phosphocreatine:ATP ratio) → contraction-band necrosis, a histologic hallmark shared with pheochromocytoma- and subarachnoid-hemorrhage-associated catecholamine cardiotoxicity, distinct from the coagulative necrosis of classic MI.
Coronary microvascular dysfunction (tissue): Impaired coronary flow reserve and abnormal microvascular resistance (documented via TIMI frame count, PET, and invasive index of microcirculatory resistance) contribute to regional hypoperfusion and stunning independent of epicardial coronary stenosis; impaired microvascular parameters independently predict worse in-hospital outcomes and delayed recovery (https://pubmed.ncbi.nlm.nih.gov/26080285/; https://pubmed.ncbi.nlm.nih.gov/37170610/).
Myocardial inflammation: Endomyocardial biopsy and imaging studies demonstrate a macrophage-predominant inflammatory infiltrate, shifted circulating monocyte subsets (increased pro-inflammatory CD14++CD16− monocytes), and elevated systemic pro-inflammatory cytokines (IL-6 markedly elevated: 23.1±4.5 pg/mL vs. 6.5±5.8 pg/mL in controls; also IL-8, CXCL1) (JACC Basic Transl Sci, https://www.jacc.org/doi/10.1016/j.jacbts.2018.08.006; PMID:30586731).
Brain-heart axis (organism level, parallel/contributing arm): Functional and structural neuroimaging shows altered connectivity and volumetric changes in the amygdala, insular cortex (especially right insula), anterior cingulate cortex, hippocampus, and brainstem autonomic centers, with hypoconnectivity between limbic and autonomic-regulatory brain networks. Elevated resting amygdalar activity has been prospectively linked to future cardiovascular events including TTS-like presentations, suggesting a pre-existing central autonomic-limbic vulnerability rather than purely reactive brain changes (Templin et al. 2019, Eur Heart J, PMID:30831580; Dichtl et al. 2020, PMID:32002630).
Downstream consequence — regional myocardial stunning: The combination of direct catecholamine toxicity, microvascular dysfunction, and altered β2AR signaling produces reversible regional wall-motion abnormality (classically apical ballooning, ~80% of InterTAK cases; less commonly mid-ventricular ~14.6%, basal/"reverse" ~2.2%, focal ~1.5%, or global) extending across multiple coronary territories.
Clinical manifestation: Acute heart failure/pulmonary edema, LVOT obstruction (dynamic, from hyperkinetic basal segments plus SAM of the mitral valve — occurring in up to 18–25% of cases and predisposing to cardiogenic shock), arrhythmia (QT prolongation, atrial fibrillation, ventricular arrhythmia/torsades), and (rarely) LV thrombus with embolic stroke or free-wall rupture.
Resolution: Because the injury is predominantly stunning without fixed necrosis/fibrosis (unlike infarction), ventricular function typically normalizes over days to weeks — though speckle-tracking strain and cardiac MR energetics studies show that subclinical dysfunction can persist despite LVEF normalization, and recurrence (4–10%) often manifests as a different anatomical variant, suggesting an underlying chronic vulnerability state rather than a single fully resolved acute event.

Estrogen-mediated modulation (protective mechanism)

Estrogen modulates cardiomyocyte β2-adrenoceptor Gs/Gi balance, preventing excessive β2AR depletion and preserving a more favorable Gs:Gi signaling ratio under catecholamine stress, which is proposed as the principal explanation for the strong postmenopausal female predominance of TTS (https://pmc.ncbi.nlm.nih.gov/articles/PMC8977075/; https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2021.737003/full — estrogen also modulates macrophage polarization via β2AR).

Cell types and biological processes involved

Cardiomyocytes (CL:0000746) — direct catecholamine toxicity, Ca²⁺ overload, contraction band necrosis, β2AR Gs→Gi switch
Cardiac microvascular endothelial cells (CL:0002350 or general endothelial cell CL:0000115) — endothelial dysfunction, impaired coronary microcirculation
Cardiac macrophages/monocytes (CL:0000235 macrophage; CL:0000576 monocyte) — myocardial inflammatory infiltrate, cytokine release
Sympathetic postganglionic neurons / adrenal medullary chromaffin cells (CL:0000166 chromaffin cell) — catecholamine release
Amygdalar and insular cortical neurons — central autonomic-limbic dysregulation

Suggested GO biological process terms: GO:0071873 (response to norepinephrine), GO:0071870 (cellular response to catecholamine stimulus), GO:0002031 (G protein-coupled receptor internalization), GO:0006979 (response to oxidative stress), GO:0055074 (calcium ion homeostasis), GO:0006954 (inflammatory response), GO:0001666 (response to hypoxia, in the context of microvascular ischemia).

Molecular profiling

Transcriptomics/proteomics/metabolomics: emerging but limited — systematic reviews describe candidate circulating biomarkers (catecholamine metabolites, endothelial dysfunction markers, cytokines, microRNAs, metabolomic signatures) still "inadequately validated" for clinical use (PMC12786540; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164033/).
Advanced technologies: No large-scale single-cell or spatial transcriptomic human TTS dataset was identified in this search; most mechanistic cellular data derive from animal models and endomyocardial biopsy immunohistochemistry.

7. Anatomical Structures Affected

Organ level: - Primary organ: Heart (left ventricle predominantly; right ventricular involvement in ~1/3 of cases, associated with worse hemodynamic compromise). - Secondary/complication organs: Brain (embolic stroke from LV thrombus, or as the trigger organ in secondary/neurogenic TTS), lungs (pulmonary edema from acute heart failure). - Body systems: Cardiovascular system (primary); nervous system (central, via brain-heart axis; autonomic nervous system); endocrine system (adrenal medulla/catecholamine axis).

Tissue/cell level: - Myocardium — predominantly apical (classic pattern), mid-ventricular, basal, or focal segments; ventricular myocardium (UBERON:0006566 or cardiac ventricle UBERON:0002082/0002084 for left/right ventricle). - Coronary microvasculature — arterioles/capillaries (UBERON:0001981 blood vessel; UBERON:0002015 coronary artery for context, though epicardial coronaries are angiographically normal). - Affected cell populations: cardiomyocytes, cardiac microvascular endothelial cells, infiltrating macrophages/monocytes.

Subcellular level: Mitochondria (GO:0005739, oxidative injury/energetic failure), sarcoplasmic reticulum/calcium handling machinery (GO:0016529), plasma-membrane β-adrenergic receptor complexes (GO:0005886).

Localization: Apex of the left ventricle is the most frequently and severely affected region (highest β-adrenergic receptor density); classic pattern is bilaterally symmetric within the ventricle (not lateralized) but extends beyond a single coronary artery's supply territory, a key diagnostic distinguishing feature from infarction.

8. Temporal Development

Onset: - Typical age of onset: adult, postmenopausal (mean ~66–68 years); rare cases in younger/premenopausal women and men, almost always with a severe identifiable physical trigger. - Onset pattern: Acute, occurring within minutes to hours of the triggering stressor.

Progression: - Disease stages: acute phase (hours to days, wall-motion abnormality and biomarker elevation), subacute recovery phase (days to weeks, LVEF normalization), and a subclinical/chronic phase in a subset of patients (persistent strain abnormalities, myocardial energetic deficits, symptoms despite normalized LVEF). - Progression rate: LV function typically normalizes within 1–4 weeks; a minority show delayed recovery, which is itself associated with higher long-term mortality and HF hospitalization. - Disease course pattern: Classically monophasic and self-limited, but recurrent in 4–10% of patients, often with a different ballooning pattern on recurrence — supporting a model of enduring physiological vulnerability rather than a single isolated insult. - Disease duration: Acute episode is self-limited (days–weeks); however, evidence of persistent subclinical dysfunction and comparable long-term mortality to MI survivors challenges the historical view of TTS as a fully benign, self-resolving condition (PMC12786540).

Patterns: - Remission is typically spontaneous with supportive care; no disease-modifying pharmacotherapy is proven in randomized trials. - Critical period: the acute 24–72-hour window is the period of highest risk for cardiogenic shock, LVOT obstruction, and malignant arrhythmia; the first 3–7 days is also the optimal imaging window for CMR-detected myocardial edema.

9. Inheritance and Population

Epidemiology: - TTS accounts for 1–3% of all acute coronary syndrome presentations and 0.5–0.9% of presentations initially thought to be STEMI. - U.S. hospital discharge data: prevalence 5.2 per 100,000 for females vs. 0.6 per 100,000 for males; overall ~0.02% of hospitalizations. Annual incidence of TTS hospitalizations rose from 5.7/100,000 person-years (2007) to 17.4/100,000 (2012), reflecting rising recognition (https://pmc.ncbi.nlm.nih.gov/articles/PMC9999670/).

Inheritance pattern: No Mendelian inheritance pattern; polygenic/multifactorial susceptibility superimposed on an acute environmental (stress/catecholamine) trigger. No penetrance, expressivity, anticipation, germline mosaicism, or carrier-frequency data apply in the classical genetic-disease sense, since no causal variant/locus is established. Rare familial case reports exist but do not establish a consistent inheritance model (https://pmc.ncbi.nlm.nih.gov/articles/PMC12292538/).

Population demographics: - Sex ratio: Strongly female-predominant — roughly 9:1 female:male in most registries (InterTAK: 89.8% postmenopausal women). - Age distribution: Peak incidence in the 6th–8th decades; mean age ~66.8 years in InterTAK. - Geographic/ethnic distribution: Recognized worldwide; originally described in Japan (Sato et al., 1990s), now diagnosed globally with increasing frequency attributed to greater clinical awareness and imaging availability rather than a true rise in underlying incidence alone. No strong evidence of founder populations or major ethnic-specific prevalence differences was identified in this search, though some registries (e.g., Palestine cohort, https://pmc.ncbi.nlm.nih.gov/articles/PMC10425303/) document regional prevalence among ACS-presenting patients. - Triggers cluster in disaster settings: notable case-series clusters following mass psychosocial stress events (e.g., a consecutive case series following the 2011 Great East Japan Earthquake, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363604/).

10. Diagnostics

Clinical tests: - Laboratory: Cardiac troponin (mild-to-moderate elevation, disproportionately low relative to the extent of wall-motion abnormality), BNP/NT-proBNP (markedly and disproportionately elevated relative to troponin — the BNP/troponin or NT-proBNP/troponin ratio is a key discriminator from ACS; median BNP/troponin T ratio ~1,292 in TTS vs. ~226.9 in MI in one study) (https://pmc.ncbi.nlm.nih.gov/articles/PMC5633535/). - ECG: Diffuse ST-segment elevation (mimicking anterior STEMI), later deep diffuse T-wave inversion, QTc prolongation. - Echocardiography: First-line imaging; identifies transient regional wall-motion abnormality extending beyond a single coronary territory, dynamic LVOT obstruction, systolic anterior motion of the mitral valve, mitral regurgitation; speckle-tracking global longitudinal strain may remain abnormal even after LVEF normalizes. - Cardiac MRI: Gold-standard adjunct — shows regional myocardial edema on T2-weighted/T2-mapping imaging without ischemic-pattern late gadolinium enhancement (contrasting with MI, and with a transmural rather than subepicardial/midmyocardial edema pattern distinguishing it from myocarditis); optimal within days 3–7 of presentation (https://pmc.ncbi.nlm.nih.gov/articles/PMC3996242/; https://pmc.ncbi.nlm.nih.gov/articles/PMC10066439/). - Invasive coronary angiography: Required in essentially all suspected cases to exclude obstructive coronary artery disease, given clinical overlap with ACS. - Endomyocardial biopsy (selected cases): reversible focal myocytolysis, mononuclear (macrophage-predominant) infiltrates, contraction band necrosis without coagulative infarct-type necrosis (https://www.revespcardiol.org/en-histological-findings-in-tako-tsubo-syndrome-articulo-S1885585714004423).

Genetic testing: Not part of routine clinical diagnostic workup — no validated clinical gene panel exists given the absence of an established causal gene; genetic/GWAS studies remain research-stage only.

Clinical/diagnostic criteria: - The current internationally accepted framework is the InterTAK Diagnostic Criteria/Score (Ghadri et al., European Heart Journal, and subsequent validation studies e.g. https://pmc.ncbi.nlm.nih.gov/articles/PMC12608723/), which incorporates: female sex, presence of an emotional or physical trigger, absence of significant coronary stenosis (or presence not fully explaining the wall-motion abnormality), transient regional wall-motion abnormality extending beyond a single coronary distribution, new ECG abnormalities (ST changes, QTc prolongation), significantly elevated NT-proBNP, relatively modest troponin elevation, and absence of myocarditis. The criteria also distinguish primary TTS (stress-activated, presenting as the primary reason for hospitalization) from secondary TTS (occurring in the context of another acute medical/surgical/neurological illness) — secondary TTS carries a worse prognosis. - Differential diagnosis: Acute MI (obstructive or with spontaneous coronary recanalization), myocarditis (differentiated by CMR LGE pattern), pheochromocytoma crisis, and reverse/atypical variant confusion with other cardiomyopathies.

Screening: No population-level or genetic screening programs exist; recognition relies on clinical suspicion at presentation with an ACS-mimicking picture plus a stress trigger.

Suggested LOINC/diagnostic terms: cardiac troponin I/T panels, NT-proBNP, 12-lead ECG, transthoracic echocardiogram, cardiac MRI with T2 mapping and LGE sequences, coronary angiography.

11. Outcome/Prognosis

Survival and mortality: - In-hospital mortality: ~2–6.5%, with some contemporary large registry data showing an upward trend (5.63% in 2016 to 8.38% in 2020) rather than the expected improvement, and more than double mortality in men versus women (11.2% vs. 5.5%) (https://www.ahajournals.org/doi/10.1161/JAHA.124.037219, PMID:40365782). - Long-term mortality: 5-year mortality rates are reported as comparable to those after acute myocardial infarction, challenging the historical characterization of TTS as uniformly benign; much long-term mortality is attributable to non-cardiac comorbidities (cancer, neurologic disease) rather than the cardiac event itself (PMC12786540).

Morbidity/complications: - Congestive heart failure ~35.9% (most common complication), atrial fibrillation ~20.7%, cardiogenic shock ~6.6–11.4%, cardiac arrest ~3.4%, stroke ~5.3%, LV thrombus 2–8%, LVOT obstruction up to 18–25% (https://pmc.ncbi.nlm.nih.gov/articles/PMC5005189/ — 101-case study of serious early complications and 2-year mortality). - Predictors of cardiogenic shock: male sex, QTc prolongation, lower admission LVEF, physical (vs. emotional) trigger, significant intraventricular pressure gradient.

Recovery/disease course: - Classic teaching: full LVEF recovery within days–weeks in the majority. However, persistent subclinical dysfunction (reduced global longitudinal strain, reduced myocardial energetic reserve on MR spectroscopy) is increasingly documented despite normalized LVEF, associated with ongoing fatigue, reduced exercise tolerance, and dyspnea. - Recurrence rate: ~4–10% (commonly cited ~10%), often with a different anatomical ballooning pattern on recurrence, and more likely in patients with ongoing physical illness, psychiatric disease, or chronic emotional stress (GEIST Registry, https://www.ahajournals.org/doi/10.1161/JAHA.118.010753).

Prognostic factors: - Male sex, secondary (vs. primary) TTS, physical/neurologic trigger, global (vs. apical) ballooning pattern, cardiogenic shock at presentation, delayed LVEF normalization, and active malignancy are associated with worse prognosis. - Cardiac biomarker ratios (BNP/troponin) aid diagnosis but are not established prognostic tools per se.

12. Treatment

Pharmacotherapy (empiric/supportive — no agent has RCT-proven disease-modifying efficacy): - Beta-blockers (NCIT:C15986 Pharmacotherapy; therapeutic_agent class NCIT — beta-adrenergic blocking agent): mechanistically attractive given the catecholamine-driven pathophysiology; evidence is mixed — a 28% reduction in all-cause mortality has been reported across pooled long-term-use studies (HR ~0.65, benefit more pronounced at 2–5 years than at 1 year), while propensity-matched analyses of early/acute-phase use show no significant effect on 30-day mortality or recurrence (https://www.jacc.org/doi/10.1016/j.jchf.2024.11.015 — GEIST Registry; https://www.sciencedirect.com/science/article/pii/S0870255123000458 — RETAKO Registry). - ACE inhibitors/ARBs: associated with improved survival, particularly in patients with severe LV dysfunction (PMC12786540). - Diuretics: for acute pulmonary congestion/fluid overload. - Mineralocorticoid receptor antagonists: considered for pronounced LV dysfunction, analogous to standard HFrEF management. - Anticoagulation: initiated for documented LV thrombus, extensive apical akinesis, or severely reduced EF, given the 2–8% thrombus incidence. - Antiarrhythmics/electrolyte management: magnesium repletion and avoidance of QT-prolonging drugs given torsades risk in the setting of QTc prolongation. - Notably, in LVOT-obstruction-positive patients, standard inotropic/positive-chronotropic heart-failure therapy is contraindicated/harmful since it worsens the dynamic obstruction; management instead favors cautious volume loading and afterload augmentation (e.g., phenylephrine-type pure vasoconstrictors) rather than inotropes.

Surgical/interventional: Not disease-directed (no surgical cure); catheter-based coronary angiography is diagnostic, not therapeutic, for TTS itself.

Mechanical circulatory support (for refractory cardiogenic shock): - Impella (percutaneous LV assist device) is increasingly preferred over intra-aortic balloon pump (IABP) and VA-ECMO because it directly unloads the LV and is compatible with the LVOTO-prone physiology; IABP use has declined (13.6%→7.4%) while Impella use has risen (29%→59.3%) in recent cohorts. ECMO without concomitant LV unloading carries higher mortality/adverse events and can paradoxically worsen LVOTO by increasing afterload and impairing LV filling; device selection should be guided by pre-implantation assessment of LVOTO and LVEDP (https://pmc.ncbi.nlm.nih.gov/articles/PMC12142538/; https://pmc.ncbi.nlm.nih.gov/articles/PMC12197009/). - VA-ECMO or the combined "ECMELLA" (ECMO + Impella) strategy is reserved for biventricular failure/most severe shock; these are temporary bridge measures, as most patients recover ventricular function within the acute phase.

Supportive/rehabilitative (emerging disease-altering strategies): - Structured cardiac rehabilitation (guided aerobic + resistance training) has been shown in recent randomized data to improve exercise tolerance, restore autonomic function, and improve quality of life — described as among "the first long-term disease-altering approaches" for TTS. - Cognitive behavioral therapy (CBT) may reduce anxiety, stress-reactivity, and recurrence risk of emotional triggers, particularly in primary or recurrent TTS.

Experimental: No approved targeted/disease-modifying pharmacotherapy exists; clinical trials (e.g., ClinicalTrials.gov NCT02307214 studying pathophysiology, NCT05977049 on psychosocial support) are ongoing rather than pivotal therapeutic trials.

Suggested NCIT treatment terms: - NCIT:C15986 Pharmacotherapy (generic, for beta-blockers, ACE inhibitors/ARBs, diuretics) - NCIT:C15747 Supportive Care - NCIT:C15302 Physical Therapy / cardiac rehabilitation (closest fit) - NCIT:C49236 Therapeutic Procedure (for mechanical circulatory support) - Therapeutic modality tagging: SMALL_MOLECULE for beta-blockers/ACEi/ARBs; DEVICE for Impella/IABP/ECMO; BEHAVIORAL for cardiac rehabilitation and CBT.

Treatment outcomes: No standardized treatment algorithm/guideline dedicated to TTS exists (unlike ACS or HFrEF); management is extrapolated from heart-failure principles with modifications for the reversible, catecholamine-driven, LVOTO-prone physiology (acknowledged explicitly in the literature as a diagnosis/management gap: "diagnosis and clinical management lacks standardized guidelines").

13. Prevention

Primary prevention: No established primary prevention strategy exists at the population level, since triggers are heterogeneous and largely unpredictable (acute emotional/physical stress, iatrogenic catecholamine exposure). Avoidance of unnecessary exogenous catecholamine administration (e.g., cautious dobutamine stress test use, epinephrine dosing in at-risk patients) is a plausible but unproven mitigation.
Secondary prevention: Early recognition via InterTAK criteria and imaging in patients presenting with ACS-mimicking symptoms after a stress trigger; screening for LVOT obstruction before administering inotropes.
Tertiary prevention: Long-term beta-blocker/ACEi therapy (of debated efficacy), structured cardiac rehabilitation, and CBT to reduce recurrence and improve functional/psychological recovery, as detailed above.
Behavioral interventions: Stress-reduction and psychological support programs (targeting the ~50–65% of cases with an identifiable emotional trigger and the high comorbid anxiety/mood-disorder burden) are an active area of clinical investigation (e.g., NCT05977049, "Psychosocial Support for Patients With Takotsubo Syndrome").
Counseling: No genetic counseling role given lack of established heritable causal variant; psychological counseling/psychiatric referral is relevant given the high burden of comorbid mood/anxiety disorders and post-event PTSD symptoms.
Public health: Not applicable in the classical infectious/environmental public-health sense; population-level stress/disaster preparedness (given documented case clustering after mass-stress events such as earthquakes) is a tangential consideration.
Prophylaxis: No established pharmacologic prophylaxis for at-risk individuals (e.g., prior TTS survivors) beyond secondary-prevention beta-blockade/ACEi noted above, and no consensus on its efficacy.

14. Other Species / Natural Disease

Taxonomy: TTS/stress cardiomyopathy is predominantly documented in humans (NCBITaxon:9606). This search did not identify robust peer-reviewed veterinary literature documenting naturally occurring takotsubo-pattern cardiomyopathy in companion animals or wildlife (e.g., no confirmed dolphin or other marine-mammal natural-disease reports were found); anecdotal/lay references to "broken heart syndrome" in animals were not substantiated by primary veterinary literature in this search.
Gene: Orthologous adrenergic receptor genes (Adrb1, Adrb2, Adra2c) are well conserved across mammals and are the genes manipulated/monitored in rodent and primate experimental models (below), but this reflects experimental induction rather than naturally occurring veterinary disease.
Comparative biology: The catecholamine-toxicity/contraction-band-necrosis mechanism is broadly conserved and is well documented in experimentally induced animal models (see Section 15) and in naturally occurring human catecholamine-excess states (pheochromocytoma, subarachnoid hemorrhage), supporting cross-context mechanistic conservation even without confirmed spontaneous non-human disease.
Transmission: Not applicable — TTS is not an infectious or zoonotic condition.

15. Model Organisms

TTS has a well-developed induced (non-genetic) animal model literature, since it is fundamentally a stress/catecholamine-response phenotype rather than a Mendelian genetic disease (comprehensive review: "Animal models of Takotsubo syndrome: bridging the gap to the human condition," 2024, https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2024.1351587/full).

Rodent immobilization-stress model (rat): Ueyama et al. (2002/2003) first restrained rats supine for ~30 minutes, producing intense emotional/physical stress, elevated plasma catecholamines, reversible ST-segment elevation, and reversible LV apical ballooning on ventriculography — normalized by combined α- and β-adrenoceptor blockade, establishing causality for the adrenergic mechanism (https://pubmed.ncbi.nlm.nih.gov/15240400/). Subsequent refinements (6 hours/day immobilization for 1–14 days) show local sympathetic cardiac remodeling by day 1, increasing ventricular tachyarrhythmia induction by day 3, and peak TTS-pattern incidence around day 5.
Catecholamine-infusion models (rat, primate): Intraperitoneal or intravenous catecholamine (epinephrine) administration reproduces takotsubo-like apical dysfunction and increased apical myocytolysis; infusion studies in non-human primates (monkeys) similarly produce apex-predominant myocytolysis with IV epinephrine infusion.
Hyperthermia-trigger rat model: demonstrates that non-catecholamine physical stressors (heat stress) can also trigger the TTS phenotype, broadening the model beyond pure catecholamine infusion (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360576/).
Receptor-blockade/genetic-pathway dissection: β1-adrenergic receptor blockade prevents stress-induced cardiac injury in rodent models, and studies of adrenergic/muscarinic receptor roles in stress-induced cardiac injury further dissect the relative contributions of sympathetic vs. parasympathetic signaling (https://link.springer.com/article/10.1007/s00424-021-02602-6).
Genetic models (knockout/transgenic): No widely used TTS-specific knockout/transgenic mouse line was identified in this search; existing models are predominantly pharmacologic/physical-stress induction in wild-type rodents rather than genetically engineered.

Phenotype recapitulation: Rodent immobilization and catecholamine-infusion models reproduce the core TTS triad — reversible apical wall-motion abnormality, ECG ST-segment changes, and catecholamine elevation — and the pharmacologic reversibility with combined adrenoceptor blockade strongly supports the catecholamine-toxicity mechanism. Limitations: rodent/primate models do not recapitulate the strong human female/postmenopausal sex bias as robustly, nor the human brain-heart axis (limbic/insular) findings, nor long-term human recurrence and subclinical-dysfunction patterns; translational fidelity to human neuro-cardiac circuitry remains an open question (a candidate HUMAN_MODEL_MISMATCH framing for a dismech entry, given documented sex-hormone-dependent human epidemiology not fully modeled in most rodent paradigms).

Model databases/resources: No dedicated TTS model-organism strain repository was identified; models are custom-induced (immobilization, restraint, catecholamine infusion) rather than sourced from standard repositories like MGI/IMPC/JAX allele catalogs, consistent with the non-genetic, stress-induction paradigm.

Summary Table of Suggested Ontology Terms for KB Curation

Category	Term ID	Label
Disease (MONDO)	MONDO:0019018	Takotsubo cardiomyopathy
Disease (Orphanet)	ORPHA:66529	Tako-Tsubo cardiomyopathy
Phenotype (HP)	HP:0100749	Chest pain
Phenotype (HP)	HP:0002094	Dyspnea
Phenotype (HP)	HP:0001657	Long QT interval
Phenotype (HP)	HP:0005110	Atrial fibrillation
Phenotype (HP)	HP:0001635	Congestive heart failure
Phenotype (HP)	HP:0001279	Syncope
Phenotype (HP)	HP:0001653	Mitral regurgitation
Cell type (CL)	CL:0000746	Cardiac muscle myocyte
Cell type (CL)	CL:0000235	Macrophage
Cell type (CL)	CL:0000166	Chromaffin cell
GO Biological Process	GO:0071870	Cellular response to catecholamine stimulus
GO Biological Process	GO:0006979	Response to oxidative stress
GO Biological Process	GO:0055074	Calcium ion homeostasis
GO Biological Process	GO:0006954	Inflammatory response
UBERON	UBERON:0002084	Heart left ventricle
UBERON	UBERON:0002094	Left cardiac atrium (context)
CHEBI	CHEBI:33569	Epinephrine
CHEBI	CHEBI:33569-adjacent	Norepinephrine (CHEBI:18357)
NCIT treatment	NCIT:C15986	Pharmacotherapy
NCIT treatment	NCIT:C15747	Supportive Care
NCIT treatment	NCIT:C15302	Physical Therapy (cardiac rehab proxy)

Key Source Citations

Ravindran et al., 2024, Intern Med J, "Clinical perspectives: Takotsubo cardiomyopathy," https://onlinelibrary.wiley.com/doi/10.1111/imj.16493
Ghadri et al., 2022, Circulation, "Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications," https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.055854
McKenzie & Bargout, 2025, J Clin Med (PMID:41517446 / PMC12786540), "Takotsubo Syndrome in 2025: Evolving Concepts in Pathophysiology, Diagnosis, and Long-Term Management," https://pmc.ncbi.nlm.nih.gov/articles/PMC12786540/
Y-Hassan & Falhammar, 2025 (PMID:40723798 / PMC12292538), "The Genetic Puzzle of the Stress-Induced Cardiomyopathy (Takotsubo Syndrome)," https://pmc.ncbi.nlm.nih.gov/articles/PMC12292538/
Templin et al., 2019, Eur Heart J (PMID:30831580), "Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome"
Dichtl et al., 2020 (PMID:32002630), "Functional neuroimaging in the acute phase of Takotsubo syndrome"
Scally et al., 2019, Circulation (JACC Basic Transl Sci companion; PMID:30586731), "Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy"
PMC9999670, "Epidemiology, Pathophysiology, Diagnosis, and Principles of Management of Takotsubo Cardiomyopathy: A Review"
JAHA 2025 (PMID:40365782), "High Mortality and Complications in Patients Admitted With Takotsubo Cardiomyopathy"
JACC Heart Failure 2024, GEIST Registry, "Beta-Blockers and Long-Term Mortality in Takotsubo Syndrome," https://www.jacc.org/doi/10.1016/j.jchf.2024.11.015
Ueyama et al., 2004 (PMID:15240400), "Emotional stress-induced Tako-tsubo cardiomyopathy: animal model and molecular mechanism"
PMC12142538, "Trends and outcomes of different mechanical circulatory support modalities for refractory cardiogenic shock in Takotsubo cardiomyopathy"
PMC9666486 / PMC10800806, cancer-TTS association literature
BMC Med Genet 2018 (PMC5842616), "Lack of genetic susceptibility in takotsubo cardiomyopathy: a case-control study"

Ask OpenScientist

OpenScientist Report

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Biochemical Markers

Diagnosis

Progression

Prevalence

Clinical Burden

Differential Diagnoses

Source YAML

References & Deep Research

Deep Research

Takotsubo Cardiomyopathy — Comprehensive Research Report

1. Disease Information

2. Etiology

Disease causal factors

Risk factors

Protective factors

Gene-environment interactions

3. Phenotypes

4. Genetic/Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

Causal chain (upstream → downstream)

Estrogen-mediated modulation (protective mechanism)

Cell types and biological processes involved

Molecular profiling

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome/Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Summary Table of Suggested Ontology Terms for KB Curation

Key Source Citations